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ABSTRACT 
Nutraceuticals face significant challenges in delivery due to poor solubility of some 
bioactives, and instability during processing. The major whey protein in bovine milk,  
ß-lactoglobulin (ß-Lg), has versatile properties and the potential for the development of 
novel delivery vehicles for bioactives. The aim of this study is to develop a solid and 
reproducible method to produce ß-Lg nanoparticles and investigate their application to 
the encapsulation of bioactives. Temperature and pH were found to be the key 
operating parameters to produce and control the size of nanoparticles. Monodisperse 
and spherical ß-Lg nanoparticles in the size range of 200-300 nm were produced at 
optimum conditions of pH (6.0) and heat load (heating incubation 75 °C for 45 mins). 
ß-Lg nanoparticles exhibited high colloidal stability (zeta potential: -37.42 mV) and high 
yield of aggregation (93%). The hydrogen bonding and hydrophobic interactions played 
a predominant role in the microstructure of these nanoparticles. Caffeine was bound to 
these nanoparticles with 13.54% as maximum encapsulation efficiency at 50:1 molecular 
ratio and the binding followed a Langmuir type isotherm. Only partial release of caffeine 
happened at gastric conditions (about 36%) whilst total release happened at intestinal 
conditions. Also, resveratrol-ß-Lg nanoparticles were produced at 181.8 nm using this 
method. Heat degradation and isomerisation of resveratrol occurred when heating at 
75°C which led to reduced antioxidant activity. Resveratrol-beta-lactoglobulin 
nanoparticles exhibited an ability to improve antioxidant activity at this temperature and 
at pasteurisation condition. Lastly, whey protein nanoparticles could be produced 
following the same method with smaller size and lower yield of aggregation. Further 
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studies should be carried out to explore other applications of ß-Lg/whey protein 
nanoparticles as a novel nanovehicle of bioactives in food products.
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CHAPTER ONE                                              
Introduction and Literature reviews                         
1.1. Introduction 
Whey is the main by-product of cheese manufacturing and the dispose of whey as food 
waste contributes to a high volume high Chemical Oxygen Demand (COD) and 
Biochemical Oxygen Demand (BOD) values, hence it has a potentially harmful 
environmental effect (Brião & Tavares, 2007; Siso, 1996; Worldbankgroup, 2007). 
However, whey contains 20% of the total protein of bovine milk, and it is an essential 
food ingredient, which provides versatile nutritional value and functional properties. 
Therefore, whey and whey proteins are widely used as food ingredient including 
formulated milk powder, animal feed and agricultural fertiliser (Ramos et al., 2017; Siso, 
1996). Main proteins in whey are ß-lactoglobulin, α-Lactalbumin, Bovine Serum Albumin 
(BSA), Lactoferrin, and Immunoglobulin (IgG). ß-lactoglobulin accounts for over 50% and 
as a member of lipocalin family, the core function of ß-lactoglobulin is to transport the 
retinol molecules, and other hydrophobic compounds (Yoav D. Livney, 2010) and this 
function has attracted the attention of food scientists among others. Since the start of 
the 21st century, ß-lactoglobulin and whey proteins have been widely studied as carrier 
or vehicles of bioactive compounds, and numerous candidates of nutraceuticals 
including vitamins, fatty acids, carotenoids, polyphenols and some antimicrobial and 
other functional bioactives have been investigated. (Castroa et al., 2017; Jia, Dumontn, 
& Orsat, 2016; Yoav D. Livney, 2010; Nicolai, Britten, & Schmitt, 2011; Shafaei et al., 2017). 
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There are different approaches delivering selected bioactives including gels, emulsions 
and microparticles. With the development of technology, the nanostructures of whey 
proteins including nanofibrils, nanoparticles, nanotubes are interesting emerging 
approaches for the delivery of bioactives (Tavares et al., 2014). These nanostructures can 
offer advantages in the improvement of solubility, bioavailability, and control release of 
nutraceuticals at specific points in the gastric-intestinal tract. (GI-tract) (Chen, 
Remondetto, & Subirade, 2006; Kontopidis, Holt, & Sawyer, 2004; Shpigelman, Israeli, & 
Livney, 2010b). Therefore, it is interesting to establish an easy and reproducible method 
to produce ß-lactoglobulin nanoparticles and to study their application for encapsulation 
of selected bioactives. 
In previous work carried out by our group, the heat-induced denaturation method was 
preliminarily investigated to produce ß-lactoglobulin nanoparticles. This was continued 
in the present work in order to achieve a robust and reproducible method to produce ß-
lactoglobulin nanoparticles. In chapter two, the investigation focused on the 
identification of the key parameters to produce ß-lactoglobulin nanoparticles and their 
influence on size; these parameters were: pH, temperature and the heating incubation 
time. 
The characteristics of the nanoparticles were determined by a range of methods. Then, 
caffeine, as the model molecule was chosen to be encapsulated by ß-lactoglobulin 
nanoparticles to study the encapsulation efficiency and their stability to simulated 
gastrointestinal conditions. In chapter three, resveratrol, a natural antioxidant, was 
chosen to be encapsulated to investigate the protective function of ß-lactoglobulin 
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nanoparticles. It is important to explore the interactions between ß-lactoglobulin and 
these bioactive molecules, the properties of these complexes and their effect on 
solubility, stability, bioavailability or control release of these bioactives. Moreover, in 
chapter four, the stability of ß-lactoglobulin nanoparticles under different types of 
processing conditions was investigated. Furthermore, the method developed here to 
produce nanoparticles with ß-lactoglobulin was applied to whey. In chapter five, the 
conclusion of this study and the suggestions for future work has been made. 
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1.2. Literature review 
1.2.1. Nutraceuticals and food applications  
In 1989, the definition of “Nutraceutical” was given by DeFelice, the chairman of 
Foundation for Innovation in Medicine. It was defined as hybrid or contraction of 
nutrition and pharmaceutical. Since then, food manufacturers and the scientific 
community were interested in the relationship between diet and health. Nutraceutical 
was defined in detail in 1994 as “any substance that may be considered a food or part of 
a food and provides medical or health benefits, including the prevention and treatment 
of disease. Such products may range from isolated nutrients, dietary, supplements and 
diets to genetically engineered “designer” foods, herbal products and processed foods 
such as cereals, soup and beverage” (DeFelice, 1994). Partly due to advances in 
technology and the internet, “nutraceutical” becomes a high-frequency word in articles, 
journals, and web pages and therefore reaches the public life. As chronical diseases 
including obesity, heart diseases, cancers and arthritis start to affect a large fraction of 
the ageing population, people start paying attention to functional foods which may have 
the ability to prevent disease and bring health benefits through diet (Wildman & Kelley, 
2006). However, the fact is that in 1992, the American market of nutraceutical was only 
around $10 billion which accounted for a small fraction of the retail food market ($504 
billion) (DeFelice, 1994). In 2010, this figure reached $140.1 billion, and the annual 
average growth rate was 14.3% which was double this number in 1999 (FICCI, 2010). 
Over last two decades, a large number of food products with added nutraceuticals have 
been developed such as calcium-enriched bread, fortified cereals, and β-carotene-
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enriched rice and soybean. Most of the nutraceuticals are found the origin to treat or 
prevent various diseases in the plant since many plants produce the constituents to 
defend themselves from infection. These constituents may have the same function to 
human infection (Rajat, Manisha, Robin, & Sunil, 2012) 
Common nutraceuticals include antioxidants, phenolic compounds, polyunsaturated 
fatty acid and probiotics and prebiotics. Some nutraceuticals suffer the limitation of 
intake. This is partly due to poor effectiveness of oral administration of antioxidants and 
polyunsaturated fatty acids. Some may be influenced by the low pH in the stomach and 
gastrointestinal conditions. In general, a small portion of these nutraceuticals can 
achieve high bioavailability in the human body (Chen et al, 2006). Flavour aspect is 
another limitation since some nutraceuticals may bring unpleasant flavour to the 
product. For example, caffeine brings bitter flavour sometimes unpleasant mouth feeling 
when the concentration is over 0.5 mmol/L (Drewnowski, 2001). 
1.2.2. Encapsulation and Nanotechnology in Food Science    
Due to the limitations above, the idea of “protection” of nutraceutical is necessary to be 
studied to improve stability, solubility, bioavailability or other health benefit properties 
of nutraceutical. Over last several decades, encapsulation has become one of the options. 
Encapsulation can be explained as coating one compound with another. At the molecular 
level, it can be understood as the confinement of small molecule within a larger molecule 
or smaller particles adhering to the larger particles. Capsules in pharmaceutical 
applications were the first developments in encapsulation, and it has over hundred 
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year’s history. Most of the capsules are gelatins or polymers from cellulose. Other 
options are the use of hydrogel, which is a water-swollen network of hydrophilic polymer. 
When it comes to food, capsules are not a good choice. Low nutrition value is one of the 
weaknesses, and these capsules do not meet the food safety requirement known as 
Generally Recognized as Safe (GRAS) as defined by U.S. food and drug administration 
(Burdock, Carabin, & Griffiths, 2006). For food applications, it is necessary to investigate 
alternative encapsulants and methods, which meet the GRAS classification, and it will be 
another health benefit if encapsulants have some nutritional values.  
In food science, encapsulation is a process to entrap one substance (active compounds) 
in another, which may be called carrier material, matrix, wall material, coating, shell or 
a membrane (Augustin & Oliver, 2012; Nedovic, Kalusevic, Manojlovic, Levic, & Bugarski, 
2011). Different encapsulation methods have been extensively researched and been 
used in the food industry including spray drying/ chilling extrusion, fluidised bed 
cocrystallization etc. (Tavares et al., 2014). Based on the materials and procedures, it has 
a simple structure (homogeneous) or complex structure (heterogeneous) which are 
schematically described in Figure 1.1 (McClements, 2012). 
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Figure 1.1: Examples of different kinds of structural organisation of possible 
encapsulation within delivery systems (The combination represents using both core-
shell and dispersion approaches).(McClements, 2012).  
Polysaccharides like starch, cellulose and their derivate and plant exudates and extracts 
are the most widely used encapsulants in the food industry (Nedovic et al., 2011) and 
protein is also considered as a good option, especially milk proteins, which have high 
nutritional value and are generally recognised as safe (Dickinson, 2003; Wang, Bamdad, 
Song, & Chen, 2012). Many studies have been conducted with milk proteins including 
casein micelle and whey proteins such as, -lactoglobulin and -lactalbumin. Also, lipids 
can be utilised as encapsulants and for transportation of nutraceutical. Some 
combinations of biopolymers have also been investigated such as chitosan/β-
lactoglobulin core-shell (Lingyun Chen & Muriel Subirade, 2005), and alginate–milk 
microspheres (Shi et al., 2013).  
Nanomaterials are defined by food and drug administration of the USA as particles with 
dimensions less than micrometre scale that exhibit unique properties (FDA, 2006). The 
same recommendation from Science and Technology committee in 2010 pointed out 
that rather than size limitation of 100nm, all materials with a dimension under 1000nm 
are considered especially in novel food regulation (Science and Technology Committee, 
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2010), but there is an emphasis on size (400nm) of nano-size carries, which can act as 
nano-capsule (Ghalandari, Divsalar, Sabour, & Parivar, 2015). Some food materials can 
build up nanoscale structure naturally. Like some globular proteins, casein micelle and 
calcium phosphate from milk, which consist of self-assembled nanostructures in the 
range of 40nm-600nm (Kruif, 1998). However, most of the biopolymers need to be 
manipulated to control the size of the particle within the range of nano size. Thus there 
are two concepts to produce nanostructure: ‘top-down structuring’, ‘bottom-up 
structuring’. ‘Top-down’ approach is to break down bulk materials by employing size 
reduction processes, while the ‘bottom up’ is basically formation by molecular the self-
assembly (Augustin & Oliver, 2012; Chen et al., 2006). These two approaches are shown 
in Figure 1.2. In detail, homogenization and wet milling are the typical examples of ‘top-
down’ methods and ‘bottom-up’ procedures use physical phenomena like precipitation 
or phase separation to form the nano-dispersion (Thies, 2012a, 2012b). The advantages 
of nanostructure has been emphasised by Chen et al. (2006) and Ramos et al. (2017): 1) 
improving the bioavailability of poor-soluble nutraceutical compounds; 2) prolonging 
the residence time in GI-tract, thus, increasing the surface availability of interactions 
with biological support; 3) Deep penetration into tissues even cells to finish control 
release. Indeed, there are some concerns from customers about the nanotechnology 
applications in food products (Kessler, 2011; Siegrist, Cousin, Kastenholz, & Wiek, 2007), 
therefore, numerous regulations have been established all over the world and some new 
requirements including new labelling system and safety information, risk assessment are 
underway (Chau, Wu, & Yen, 2007).  
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Figure 1.2: Schematic representation of food-protein-based materials as nutraceutical 
delivery systems (Chen et al., 2006). 
Therefore, according to the basic understanding, the theory of encapsulation and methods to 
build nanostructure, whey protein can be a good candidate for both “Top down” and “bottom 
up” approaches. The next section will introduce whey protein and β–Lactoglobulin.  
 
1.2.3. Whey protein: composition and functions 
After centrifugally separating the cream from milk by traditional fractionation, whey 
proteins are included in the serum. It is the by-product of cheese making and it remains 
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in the supernatant after the isoelectric precipitation of the caseins (cheese curd) from 
skim milk at pH 4.6. Similarly, sweet whey is the by-product of rennet or natural enzyme-
produced cheese manufacture at higher pH 6.7 (Yoav D. Livney, 2010). Whey protein 
concentrates (WPC) are obtained from whey by ultrafiltration, and whey protein isolates 
(WPI) by subsequent diafiltration or ion exchange, then drying (>85% protein) (Singh & 
Ye, 2014). Whey protein contributes 20% of milk protein, and the remaining 80% is in 
casein. Briefly, whey proteins mainly including β–Lactoglobulin (β-Lg), α–Lactalbumin (α-
La), Bovine serum albumin (BSA), Immunoglobulin G (IgG) and Lactoferrin (Lf) are shown 
in Table 1.1. 
Table 1.1: The main proteins in milk (Tavares et al., 2014). 
Origin Proteins 
 
Concentration in 
milk (g/kg) 
Molecular 
weight (kDa) 
Isoelectric 
point 
Synthesised in 
the mammary 
gland 
Casein 
micelle 
  26 ≈105 (100-
500nm) 
4.6 
Casein 
fractions 
αS1 10.7 23.6 4.9 
αS1 2.8 25.2 5.2 
β 8.6 24 5.4 
From blood Κ 3.1 19 5.6 
Whey 
protein 
β-Lactoglobulin 3.2 18.3 5.2 
α-Lactalbumin 1.2 14.2 4.3-4.7 
BSA 0.4 66.3 5 
Lactoferrin 0.1 83 8.5 
 
Whey proteins have essential nutritional value and health benefits. First of all, an 
important role played by whey proteins is that it contains an abundant amount of all 
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nine essential amino acids. Especially, cysteines present in β–Lactoglobulin are key 
amino acids for stimulation of glutathione synthase in the liver. Also, a review paper 
(Markus, Olivier, & Haan, 2002) mentioned that α-Lactalbumin is an abundant source of 
essential amino acids tryptophan and cysteine. They are the precursors of serotonin and 
glutathion, which improve the ability to reduce the depressive mood. Similarly, β-
Lactoglobulin is the precursor of bioactive peptides with a variety of bioactivities like 
antihypertensive, antimicrobial, antioxidative, anticarcinogenic etcetera (Castroa et al., 
2017; Korhonen, 2009). For example, several studies suggest that bioactive peptides 
from β-Lactoglobulin have an ability as angiotensin I-converting enzyme (ACE) inhibitor 
(Chatterton, Smithers, Roupas, & Brodkor, 2006; Ortiz-Chao et al., 2009; Pihlanto-
Leppälä, 2001). Table 1.2 shows the major bioactive peptides from the whey protein and 
their bioactivities. 
Table 1.2: The summary of whey protein- derived bioactive peptides (Meisel & 
Bockelmann, 1999).  
Bioactive peptides Protein precursor  Bioactivity 
α-lactorphin α-Lactalbumin Opioid against 
β-lactorphin β-Lactoglobulin Opioid against 
Lactoferroxins Lactoferrin Opioid antagonist 
Lactokinins α-lactalbumin,β-lactoglobulin, serum albumin ACE-inhibitory 
Lactoferricin Lactoferrin Antimicrobial 
 
Unlike intrinsically unstructured casein, whey proteins are typically globular proteins and 
have various biological functions (Tavares et al., 2014). β-Lactoglobulin, has a structure 
similar to retinol-binding proteins, which can bind hydrophobic ligands like fatty acids 
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and vitamins, even though the biological functions of β-Lactoglobulin still remain unclear 
(L. Sawyer, 2013), but some of the publications indicate that β-Lactoglobulin inhibits the 
hydrolysis of phosphate by phosphoprotein phosphatases in the spleen (H. M. Farrell & 
Thompson, 1990). In contrast, α-Lactalbumin has specific functions to the regulatory 
protein of lactose synthase enzyme system (Brew, 2013). Other minor whey proteins 
like blood serum albumin (BSA) acts as minerals and hydrophobic molecules 
transportation role in blood plasma (Gelamo, Silva, Imasato, & Tabak, 2002). Lactoferrin 
(LF) is an iron-binding glycoprotein which exists not only in milk but other body 
secretions. Another important role of Lactoferrin is that it can impede iron utilisation by 
bacteria, thus it has a bacteriostasis function (Lönnerdal & Suzuki, 2013).  
1.2.4. Beta-lactoglobulin  
As the major whey protein, beta-lactoglobulin is chosen as the main encapsulant in this 
work. Comprehensive understanding of the molecular structure and conformation of -
lactoglobulin would lead to better choices of processing conditions of nanoparticle 
preparation and the binding ligands selection. Beta-lactoglobulin is abundant in bovine 
milk at a concentration 0.2-0.3 g/100 ml (Bell & Mckenzie, 1964; J.Cerbulis & 
H.M.FarrellJr., 1975; Lindsay Sawyer & Kontopidis, 2000), while it is rare in human milk. 
It is a member of lipocalin family, which has a similar common structure and exhibits 
high affinity and selectivity for hydrophobic molecules, especially act as the transporters 
of retinol (Flower, 1996; Flower, North, & Attwood, 1993; Ganfornina Álvarez, Sánchez 
Romero, Greene, & Flower, 2006; Kontopidis et al., 2004). Beta-lactoglobulin contains 
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162 amino acids residues with molecular weight 18.3 kDa including two disulphide 
bonds (Cys 66–Cys 160 and Cys 106–Cys 119) and a free thiol (Cys 121). There are two 
genetic variants A and B, which is different in two amino acid residues; Asp 64 and Val 
118 in variant A are replaced by Gly and Ala in variant B, respectively (Zsila, Bikádi, & 
Simonyi, 2002). The structure of beta-lactoglobulin has been one of the important 
targets of molecular biological science and protein science due to: 
1) Large molecular size, so it is a good example to understand the principles of 
denaturation and aggregation of proteins in this size.  
2) Binding ligands, especially small hydrophobic molecules, is another attractive 
characteristic of beta-lactoglobulin. (Sakurai, Konuma, Yagi, & Goto, 2009) 
The schematic graph illustrates the three-dimensional structure and amino acid 
sequence of beta-lactoglobulin in Figure 1.3 (A) and (B). Several groups use X-ray 
crystallography and solution nuclear magnetic resonance to carry out the structure 
studies. Briefly, like other lipocalin, it is made of eight strands of antiparallel β-sheet (A-
H blue strands) to wrap round to the central calyx or β-barrel, which is flanked with a 
three-turn α-helix (between H and G strands) (Edwards, Creamer, & Jameson, 2009; 
Kontopidis et al., 2004; Papiz et al., 1986; Sakurai et al., 2009). The ninth strand (I strand) 
plays an important role of the dimer interface at neutral pH (Bewley, Qin, Jameson, 
Sawyer, & Baker, 1997).    
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Figure 1.3: The 3D structure and amino acid sequence of bovine beta-lactoglobulin 
(Sakurai et al., 2009). A: The 3D structure of bovine beta-lactoglobulin, B: the amino 
acid of bovine -lactoglobulin. 
 
The connections between open ends AB, CD, EF, and GH is longer and more flexible than 
closed BC, DE, and FG (Sakurai, 2009). The central calyx surrounded by hydrophobic 
A  
B 
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residues is the principal main ligand-binding site (Lange, Kothari, Patel, & Patel, 1998; 
Narayan & Berliner, 1997). Alternatively, some studies suggest that there may be some 
more binding points at the surface of beta-lactoglobulin but not sufficient proofs of 
crystallographic data (the second point is located at Trp19, Tyr20, Tyr42, Gln44, Gln59, 
Gln68, Leu156, Glu157, Glu158 and His161 and third point is located at Tyr102, Leu104, 
and Asp129 ) (Shafaei et al., 2017; Yang et al., 2008; Zhang, Liu, Subirade, Zhou, & Liang, 
2014; Zsila et al., 2002). 
Among various factors influencing the structure of β-lactoglobulin, temperature and pH 
are the most important parameters that may affect the cross-linking and network 
among protein molecules. 
At neutral conditions, it is believed that -lactoglobulin exists as a dimer in the aqueous 
solution. Actually, it can be understood that the native β-lactoglobulin present as an 
equilibrium of monomers and dimers (J.N.deWit, 2009; Bin Y. Qin et al., 1998; Taulier & 
Chalikian, 2001). When heating the beta-lactoglobulin solution, the dimer changes to a 
monomer at elevated temperature (50°C). Continuing heating beta-lactoglobulin will 
result in an exposure of previous hidden hydrophobic residues and thiol groups. Also, 
the conformation of native beta-lactoglobulin will change to a “molten-globule state” 
(de Wit，2009 and Sawyer, 2013). That is the start of the irreversible modifications 
between 60 and 70 °C. Further heating (65-75°C) will cause some oligomers due to 
exposure of thiol groups and thiol/thiol oxidation reactions. The large aggregation occurs 
via disulphide bond and hydrophobic force when the temperature reaches 75°C but 
below the 100°C. The schematic graph is illustrated in Figure 1.4.  
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Figure 1.4: The structural changes of β-lactoglobulin by the temperature increasing at 
neutral pH. (J.N.deWit, 2009). 
 
Moreover, pH is another important factor will affect the conformation and structure of 
-lactoglobulin. The isoelectric point (pI) of β-lactoglobulin is around 4.7-5.1 (Edwards 
et al., 2009; Kontopidis et al., 2004; Sakurai et al., 2009). This is an important pH at which 
no electrical charge at the surface of the protein. Hence, the closer to its pI, the lower 
electrical repulsion force. The most famous conformational change is the Tanford 
transition presented by Tanford, Bunville, and Nozaki (1959), which propose EF-loop 
close the hydrophobic cavity of the β-barrel of the β-Lg molecule below pH 7 and open 
the cavity above pH 7 (Sakurai & Goto, 2006). Moreover, a three-step mechanism for 
the Tanford transition is suggested at pH 6.2, 7.1 and 8.2 due to open or closure E-F 
loops. Meanwhile, a widely pH study by Taulier and Chalikian (2001) shows more 
complex structural changes in the range of pH 1 to pH 13: five pH-dependent structural 
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states including pH 2 transition (pH<2), dimer-to-monomer transition (pH 2.5- pH 4.0), 
pH 5 transition (pH 4.5- pH 6.0, native form to acidic form), the Tanford transition (pH 
6.0- pH 8.0), the base-induced denature (pH>9.0). To emphasise, only pH 5 transition 
has no significant alteration in the secondary structure of beta-lactoglobulin. 
Except for these two factors above, there are still some other factors including the 
concentration of β-Lg, which determines the total number of disulphide bonds and the 
chance of protein-protein interactions, and the Ionic strength, which relates more to the 
types of salt added and addition methods. When producing nanoparticles to 
encapsulate nutraceutical or bioactive food ingredients, all of these factors are under 
consideration. Therefore, under different conditions, various structure and 
conformation changes will result in a complex three-dimensional network of 
aggregation.  
1.2.5. Encapsulation applications of whey protein and ß-lactoglobulin 
Whey protein has been considered as an encapsulation matrix to deliver nutraceuticals 
by using the different structures including hydrogel, emulsions, supra-molecular 
structures, microparticles and nanoparticles. There are two main strategies to achieve 
the nanoparticles: heat-induced aggregation and desolvation.  
The typical desolvation reagents include ethanol and acetone. Sanghoon Ko and 
Sundaram Gunasekaran (2006) prepared sub-100nm beta-lactoglobulin nanoparticles 
with acetone in the range of 131±8 nm and 59±5 nm at pH 9, without preheating and 
with preheating (60°C for 30 min) respectively. They found that preheating had a 
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function of lowering particle size and improving the uniformity at the alkaline conditions. 
Gülseren, Fang, and Corredig (2012) were also able to produce nanoparticles of whey 
protein with a diameter <100 nm by using ethanol as the desolvation buffer. They found 
that this type of nanoparticles was not stable at neutral pH, and acidification to pH 3 
was necessary to stabilize the particle size. On the other hand, they observed that 
heating led to stable nanoparticles but enhancement in size. At the same time, they used 
this nanoparticle to encapsulate the Zinc and achieved high encapsulation efficiency 
(over 80%) (Gülserena, Fang, & Corredig, 2012). These two examples indicated that the 
interactions to form nanoparticles were different depending on the desolvation reagent. 
In most cases, the influence on the binding properties by organic reagent remains 
unclear (Chen et al., 2006), and adding organic solvents for food applications is highly 
questionable as it is not generally recognised as safe. Therefore, there were some 
limitations using the desolvation method for food products. Moreover, ethanol as 
desolvation buffer would definitely influence the groups of customers due to the 
alcoholic content.   
Alternatively, there are numerous studies among several groups using the heat-induced 
aggregation to produce nanoparticle. Giroux, Houde, and Britten (2010) conducted an 
experiment with the heating denatured whey protein following the pH cycling method. 
After heating at 80°C for 15 min, nanoparticles around 50 nm were produced, and then 
an acidification (5.0, 5.5, 6.0) ageing step, as well as the addition of Calcium (0, 2.5, 5 
mM), was introduced to promote aggregation. They found that the nanoparticles were 
mainly cross-linked by disulphide bonds, while hydrogen bonds and hydrophobic also 
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contributed to internal structure. Calcium promoted protein aggregation, but it was not 
required to maintain the stability. Phan-Xuan et al. (2014) produced beta-lactoglobulin 
microgels around 260-440 nm in the range of pH 5.8-7.2 with Calcium (0.1M, 0.5M) by 
heating at 85°C for 15 hours. Calcium promoted the aggregation of microgels, and the 
net charge of native protein was the crucial parameter for the formation of microgels, 
which can be controlled by adding calcium or the pH adjustment. Similar particle size 
(50-300nm) was reported under mildly acidic conditions (pH 5.7-5.9) with 1.0 % β-Lg and 
heating at 70°C for 24 hours and 85°C 8 hours respectively (Laurence Donato, Christophe 
Schmitt, Lionel Bovetto, & Martine Rouvet, 2009). They proposed a model of β-Lg 
microgel aggregation pathway and emphasized the importance of pH in this pathway. 
Oancea et al. (2017) achieved that 98-192 nm nanoparticles of β-Lg by heating 0.2% 
protein solution in pH 7.7 Tris-HCl buffer at 70oC for 20 mins. Among of all these studies, 
whey protein or β-Lg solution was heated at similar pH range but with different heat-
load.  
 
On the other hand, the application of nanoparticles has been investigated widely. 
Available binding ligands with native β-Lg have been explored since the middle of last 
century with SDS as the first binding ligand (Davis & Dubos, 1947). There is a good 
summary by L. Sawyer (2013). Briefly, the fatty acid, vitamins, and retinol and numerous 
hydrophobic compounds have been bound to beta-lactoglobulin. The scientific society 
makes great efforts to use β-Lg/ whey nanoparticles as encapsulants to deliver bioactives. 
Patricia Zimet and Yoav D. Livney (2009) achieved encapsulation of low-water soluble 
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ω-3 fatty acids (166 times higher) in β-Lg nanoparticles (~100 nm) and proved its 
effectiveness of protection against oxidation. Shpigelman et al. (2010b) and Avi 
Shpigelman, Yifat Cohen, and Yoav D. Livney (2012) continued to work on the thermally-
induced beta-lactoglobulin-EGCG nanocomplexes and achieved high encapsulation (60-
70%) and protection functions (33-fold lower initial degradation rate and control release 
in the intestine. Madalena et al. (2016) produced beta-lactoglobulin nanoparticles (172 
nm) at pH 6, 80 °C for 10 min and achieved encapsulation of riboflavin (26% association 
efficiency) and control release in the small intestine. Stability of beta-lactoglobulin 
nanoparticles over 14 days in stimulant conditions (yoghurt, pH 3.45) was achieved.  
Despite all this work being done on the formation of nanoparticles with β-lactoglobulin 
and their application to encapsulation of bioactives, there is a need to establish a robust 
and reproducible method to produce β-Lg nanoparticles which can be applied to the 
encapsulation of bioactives. 
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1.3. Aims and objectives  
Beta-lactoglobulin, the major whey protein, has interesting binding ligand properties 
and a potential to be a delivery system for bioactive compounds. There are still some 
challenges to develop an approach to use beta-lactoglobulin as bioactives carrier in food 
products. The aim of this work was to explore the feasibility and operability to produce 
β-Lg nanoparticles as a novel delivery vehicle for nutraceuticals and try to apply these 
nanoparticles to the encapsulation of some interesting molecules. Also, if given a 
consideration to practical and economical aspects, it is worth trying to produce whey 
protein nanoparticles using the same method. Therefore the specific objectives of this 
research were : 
1. To investigate the main operating parameters to produce β-Lg nanoparticles and 
their influence on the size of nanoparticles in order to establish a robust and 
reproducible method to produce β-Lg nanoparticles. 
2. To characterise these nanoparticles including size, shape, charge and main 
interactions responsible for the stabilisation of these nanoparticles.  
3. To produce caffeine-loaded β-Lg nanoparticles and examine the encapsulation 
efficiency, the caffeine release under simulated gastric fluid and intestinal conditions 
and to elucidate the mechanism of encapsulation. 
4. To produce resveratrol-β-Lg nanocomplexes and investigate the effect of these 
nanoparticles and native β-lactoglobulin on the solubility and stability of resveratrol 
under different thermal processing conditions. 
5. To study the stability of β-Lg nanoparticles under various processes/conditions 
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including ethanol concentration, different speed of centrifugation and freeze drying.  
6. To produce whey protein nanoparticles using the same method as for β-Lg and make 
a comparison between β-Lg nanoparticles and whey protein nanoparticles.   
7. To evaluate the production of nanoparticles with -lactoglobulin and whey proteins 
in the context of industrial applications for encapsulation of food ingredients.  
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ABSTRACT 
The production of β-Lg nanoparticles by a simple heat-induced denaturation method 
without the need to add chemicals was performed at different conditions of pH, and 
temperature of denaturation. Optimum conditions were set as 0.2 % w/v β-Lg, pH 6 and 
simply heating in water bath at 75°C for 45 minutes. At these conditions, a monodisperse 
solution with colloidal stability was obtained, and the yield of aggregation was over 90%. 
Shape and size of nanoparticles were determined by Dynamic Light Scattering technique 
and by electron microscopy. A monodisperse particle size distribution of spherical shape 
particles (200nm-300nmin) diameter was obtained. The stability of the aggregates 
towards various types of dissociating buffers was studied. Sodium dodecyl sulphate (SDS) 
and urea had a strong effect on the size of the nanoparticles, while 2-Mercaptoethanol 
and Dithiothreitol (DTT) had no significant effect. Therefore hydrogen bonding and 
hydrophobic interactions were the predominant interactions responsible for the 
microstructure. Maximum yield of caffeine encapsulation of 13.54% was obtained at 
caffeine to the β-Lg molar ratio of 50:1. Rapid nanoparticle degradation and increase of 
polydispersity during the incubation of β-Lg nanoparticles at simulating stomach 
conditions time was observed due to enzymatic attack. Nevertheless, little release of 
entrapped caffeine was noted. Total release was achieved at intestinal conditions. Finally, 
the adsorption of caffeine to both native and denatured β-Lg followed a Langmuir 
adsorption isotherm model, and caffeine had three times more affinity for partially 
denatured β-Lg in nanoparticles than for native protein. 
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2.1. Introduction 
Whey is the principal by-product of cheese manufacturing, and it represents 85-95% of 
the initial volume of processed milk with high Chemical oxygen demand (COD) and 
Biochemical oxygen demand (BOD) values hence its disposal would have a negative 
environmental impact. The total world production of liquid cheese whey in 2008 was in 
the region of 187 million metric tons and of this 3.2 million metric tons were industrially 
utilised and processed into higher added value products such as, whey powder, whey 
proteins concentrate and whey protein fractions (Afferstsholt & Palmer, 2009; C. 
Baldasso , T.C. Barros, & Tessaro, 2011); the remaining whey is used for animal feed, 
fertilisers, baby milk powder and some it is just dumped. Whey is a valuable source of 
proteins (about 0.8-0.9% protein) with high nutritional value and additional biological 
properties as well as numerous functional properties such as gelation, emulsifying and 
foaming properties (Jauregi & Welderufael, 2010). The major whey protein, beta-
lactoglobulin (β-Lg) which comprises 51 % (w/w) of total protein has very interesting 
aggregation properties which have been exploited for its application as an encapsulant 
(Chen et al., 2006; H. J. Giroux, J. Houde, & M. Britten, 2010; Jones, Lesmes, Dubin, & 
McClements, 2010). This protein is predominantly dimeric under physiological 
conditions, but dissociates to a monomer at about pH 3 (Tauliera & Chalikiana, 2001); its 
isoelectric point (pI) is 5.13. Four out of its five cysteine residues form two disulfide 
bridges leaving a free reactive thiol group that appears to be responsible for the 
formation of covalent aggregates upon heating (L. Sawyer, 2002). Also β-Lg possess a 
hydrophobic pocket that when exposed by, for example, heat denaturation forms 
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aggregates by hydrophobic interactions. These aggregation properties can be 
manipulated by changing temperature, pH, and ionic strength. Under prolonged heating 
at low pH and low ionic strength, a transparent `fine-stranded' gel is formed, in which 
the protein molecules assemble into long stiff fibers and also can produce nanoparticles 
(S. Ko & S. Gunasekaran, 2006). 
Food protein-based nanoparticles are of great interest because they are Generally 
Recognised as Safe (GRAS), easy to prepare, no need for chemical cross-linking agents 
during preparation, better control over size distributions (Chen et al., 2006; Gunasekaran, 
Ko, & Xiao, 2006). β-Lg is able to aggregate forming nanoparticles that have some 
technological advantages as an encapsulant for bioactives; among others: inexpensive, 
food grade and non-toxic material, capable of solubilizing and protecting hydrophobic 
biologically active molecules in aqueous media as well as capable of retaining sensory 
qualities, and promote bioavailability of hydrophobic biologically active molecules. In 
this sense, when electrically charged, β-Lg is also able to ion binding and electrostatic 
complex formation, self and co-assembly and covalent conjugation (Y. D. Livney, 2010). 
In previous works, β-Lg nanoparticles have been applied as carriers for a range of 
nutraceutical products such as, polysaccharides, pectin, carageenan or chitosan (L. Chen 
& M. Subirade, 2005; Jones et al., 2010; Ron, Zimet, Bargarum, & Livney, 2010; P. Zimet 
& Y. D. Livney, 2009) where β-Lg forms complexes with each of these products. The 
complexity of method and materials used for the production of such complexes hinders 
the possibility of scaling up production. On the other hand, simple production steps such 
as desolvation with ethanol can produce nanoparticles without application of heat, thus 
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making it very feasible for heat-labile bioactive components (Gulseren, Fang, & Corredig, 
2012). Nonetheless, usage of organic solvents for food application is still the major 
drawback for this method (Nicolai et al., 2011).  
Caffeine is an amphiphilic alkaloid drug that has a strong bioactivity acting as a stimulant 
drug of the central nervous system. For this reason is considered the most popular legal 
stimulant consumed in the world, mainly in the form of coffee and tea infusion (Gilbert, 
1984). In the last years, several energy drinks containing caffeine have been launched to 
the market having a great success and customer acceptation (Somogyi, 2010). 
Unfortunately, caffeine has very bitter taste and unpleasant aftertaste limiting or even 
excluding their use from many foods and drink formulations. Encapsulation of caffeine 
enables bitterness masking, and it can be easily added to food and drink products 
without changing the flavour or increasing the bitterness level. In addition, 
encapsulation could provide protection against harsh processing conditions and 
controlled release.  
The aim of this study is to investigate the production of β-Lg nanoparticles by a simple 
heat-induced denaturation method without the need to add chemicals and/or other 
reagents and to investigate their application to the encapsulation of caffeine. Particles 
were characterised in terms of size by Dynamic Light Scattering technique, fluorescence 
and by electron microscopy. Stability to buffers was examined as an indirect 
measurement of the internal forces responsible for the molecular network within the 
particles. This led to an improved understanding of the mechanism of aggregate 
formation and their interaction with caffeine. 
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2.2. Materials and Methods 
2.2.1. Materials 
β-lactoglobulin (β-Lg) from bovine milk, ≥90% PAGE lyophilised powder was purchased 
from Sigma-Aldrich (United Kingdom) for all the experiments. The material used for 
encapsulation was caffeine (99% purity) also obtained from Sigma-Aldrich (United 
Kingdom).   
2.2.2. Methods 
2.2.2.1. Preparation of β-lactoglobulin nanoparticle 
The β-Lg powder was dispersed in deionized water to make 50 ml 0.2 % w/v β-Lg stock 
solution and it was stirred magnetically for about 2 h at room temperature. This stock 
solution was stored in a 50ml Falcon tube (VWR International, 525-0403, USA) at 4°C 
over the whole night to complete hydration. In order to prevent the growth of 
microorganisms, 200 ppm sodium azide was added.  
A 5 ml sample from the β-Lg stock solution was added into 15ml a Falcon tube (VWR 
International, 5250401, USA) and after warming the sample up to room temperature, 
the pH was measured. Then the pH of the sample was adjusted to 6.0 (except when the 
pH effect was investigated) using a pH meter (Mettler Toledo, Switzerland) with 0.1M 
HCl and 0.1M NaOH. After this, the Falcon tube containing the sample was introduced 
into a water bath (Grant Instrument Ltd., Cambridge, United Kingdom) that had been 
previously heated at 75 °C. The sample was left for 45 minutes at this temperature except 
when the effect of heat load was investigated. The temperature of the sample was 
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monitored, and it took about 12-14 minutes for the temperature in the samples to reach 
the water temperature (75 °C). After the set heating time, samples were moved to an ice 
bath for 10 minutes to terminate incubation, and the pH of the sample was measured. 
For experiments where pH effect (5.7-6.2) was investigated, nanoparticles were 
produced following procedure described above but initial pH of sample was changed. 
For experiments where temperature effect was investigated, samples were heated at 
60 °C and 75°C; all other conditions were kept constant (0.2 % w/v of β-Lg, pH 6 and 
heating time 45 minutes). For experiments where the heating time (heat load) effect was 
investigated, nanoparticles were produced following procedure described at 0.2 % w/v 
of β-Lg, pH 6 and 75°C but at varying heating incubation time: 15, 25, 35, 45, 55, 65, and 
75 min. 
2.2.2.2. Preparation of caffeine encapsulated β-lactoglobulin nanoparticles  
The experiment on the encapsulation of caffeine was conducted only with 0.2% (w/v) 
dispersions. Caffeine (99% purity) was added to the β-Lg dispersions prior to pH 
adjustment to obtain 10:1, 20:1, 50:1, 100:1, 200:1 caffeine to β-Lg molar ratios. A 
certain volume of stock caffeine solution (10mg/ml) was mixed with protein samples to 
achieve 10:1, 20:1 caffeine to β-Lg molar ratios, respectively. The final protein 
concentration after pH adjustment and caffeine addition was 0.2 % (w/v). Caffeine 
powder was added into samples to obtain 50:1, 100:1, 200:1 caffeine to β-Lg molar ratios, 
respectively. Once caffeine was added to the β-Lg solution, the encapsulation method 
proceeded in the same way as the nanoparticle formation procedure described in 
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section 2.2.2.1. 
2.2.2.3. Particle size distribution 
The Z-average hydrodynamic diameter of β-Lg nanoparticles was measured by dynamic 
light scattering technique using Zetasizer Nano Z (Malvern Instruments Inc., Malvern, 
United Kingdom) at 25 ± 0.1°C and five measurements were taken for each sample. The 
measurement was determined by considering the refractive index of β-Lg as 1.45 and 
that of the dispersant medium (deionized water) as 1.33. The z-average mean was 
calculated from the intensity of light scattered from the nanoparticles, based on Stokes-
Einstein equation, which assumes that all particles are spherical. Each sample was 
measured five times and the mean and standard deviation was determined. In some 
case samples were diluted in order to operate at concentrations appropriate for DLS (as 
indicated by machine). When samples were incubated with different dissociating buffers, 
the refractive index of these buffers was taken into account: (i) 10M urea, refractive 
index 1.370 (Warren & Gordon, 1966) (ii) 0.1M Mercaptoethanol, refractive index 1.500 
(Sigma-Aldrich, 2017), (iii) 1.0 % (w/v) SDS, refractive index 1.334 (Tumolo, Angnes, & 
Baptista, 2004), (v) 0.1 M DTT, refractive index 1.576 (ChemBK, 2017). 
2.2.2.4. β-lactoglobulin aggregation  
The degree of thermal aggregation for β-Lg was determined by separation of denatured 
β-Lg nanoparticles from native β-Lg using centrifugal ultrafiltration Vivaspin® 20 
(Sartorius Stedim Biotech, Germany) with 50 kDa molecular weight cut-off membrane. 
To quantify the amount of native and aggregated β-Lg, 5ml of the heated β-Lg solution 
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following the method described in section 2.2.2.1 was centrifuged at 2000 rpm for 15 
minutes to collect the retentate as well as the permeate; the retentate and permeate 
volumes were determined by weight. The concentration of the native β-Lg remained in 
permeate was determined by bicinchoninic acid (BCA) method. In brief, 0.1 ml of the 
permeate solution was added to 2 ml of BCA working reagent (bicinchoninic acid and 
copper (II) sulphate pentahydrate), followed by incubation at 37°C for 30 min. The 
reaction solution was measured at 562 nm in an Ultrospec ® 1100 Pro UV-vis 
spectrophotometer (United Kingdom). The percentage of protein aggregated was 
determined by measuring the total protein in the permeate followed by mass balance 
on protein. 
2.2.2.5. Microscopy Method. 
Environmental Scanning Electron Microscopy (ESEM) image was carried out on samples 
produced at the optimum conditions - 0.2 % β-lactoglobulin, pH 6.0, at 75 °C for 45 min. 
The microscope used was an FEI Quanta 600, operated in environmental mode with a 
water vapour pressure of 822.46Pa, and a specimen temperature of 5°C. The 
accelerating voltage was 20 kV. One drop of β-lactoglobulin nanoparticles sample was 
dispersed at the surface of the metal stub of the microscope and was dry at the room 
temperature to achieve the evaporation of some moisture content, which ensured that 
nanoparticles images were easier to be captured.   
2.2.2.6. Fluorescence measurement of protein solutions 
The degree of β-Lg conformational changes on fluorescence emission of tryptophan (Trp) 
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was accessed by fluorescence spectrophotometer with temperature controller (Varian 
Cary Eclipse, United Kingdom). Fluorescence spectra were obtained after excitation at 
280 nm, scanning an emission wavelength range between 290 nm to 510 nm, using 5nm 
excitation and emission slits wavelength. The data was collected by Cary Eclipse software 
version 2 (Varian Cary Eclipse, United Kingdom). Samples of native β-Lg, heated β-Lg 
nanoparticles, and caffeine loaded β-Lg nanoparticles were analysed in duplicate at a 
constant temperature of 20°C. 
2.2.2.7. Stability against dissociating buffers  
All samples and buffers were filtered by 0.45 μm filters before the incubation with 
dissociation buffers. β-Lg nanoparticle dispersions were mixed with equal volume of 
various dissociating buffers: (i)10M urea (ii) 0.1M mercaptoethanol, (iii) 1% (w/v) SDS, 
(v) 0.1 M DTT. Dispersions were incubated for 60 min with each buffer, and the particle 
size was measured following the method described in section 2.2.2.3.   
2.2.2.8. Zeta potential 
Zeta potential of the sample was measured by Dynamic light scattering technique using 
Zetasizer Nano Z in Electrophoretic Light Scattering mode (Malvern Instruments Inc., 
Malvern, United Kingdom) at 25 ± 0.1°C and five measurements were taken for each 
sample. A folded capillary cell (DTS1070) was used to measure the zeta potential. The 
cell was washed with ethanol and deionized water before each measurement. 
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2.2.2.9. Caffeine determination by HPLC 
An isocratic Reversed phase High-Performance Liquid Chromatography (RP-HPLC) 
equipped with Gilson Model 302 Pump, CE212 Variable wavelength ultraviolet detector 
and Hewlett Packard 3396A integrator was used to quantify the caffeine concentration 
contained in permeate. The column used was Ace 5 C18, 25cm × 4.6mm (Hinchhrom 
Limited, United Kingdom), operated at 25 ± 1°C, the flow rate was 1.0 mL/min, with 50 
μL injection volume, while mobile phase comprised of methanol/water (50/50). 
Absorption wavelength was selected at 273 nm, which is the maximum wavelength for 
caffeine. Standard solution of caffeine was prepared in deionized water in the range of 
concentrations from 0.001% to 0.01% (w/v). A standard calibration plot for was prepared 
by plotting concentration versus area from which the concentration of caffeine was 
determined in a range of samples.  
2.2.2.10. Encapsulation efficiency 
To study the encapsulation efficiency of caffeine into β-Lg nanoparticles, the caffeine 
encapsulated by the β-Lg particles was separated from free caffeine by centrifugal 
ultrafiltration membranes of 50 KDa MWCO, Vivaspin® 20 (Sartorius Stedim Biotech, 
Germany). To quantify the amount of free and entrapped caffeine, 5 ml of protein and 
caffeine solution prepared according to section 2.2.2.2 was sampled and centrifuged for 
30 min at 2000 rpm. The retentate was removed carefully by pipette for further analysis 
while the permeate was used for determination of free caffeine using RP-HPLC. The 
amount of the entrapped caffeine was determined based on the determination of free 
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caffeine in the permeate and by applying a mass balance. The entrapment efficiency of 
caffeine was calculated based on the following equations (Eq. (1)): 
 
𝐸𝑛𝑡𝑟𝑎𝑝𝑚𝑒𝑛𝑡 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (%)  =
𝑚𝑎𝑠𝑠 𝑜𝑓 𝑐𝑎𝑓𝑓𝑒𝑖𝑛𝑒 𝑒𝑛𝑡𝑟𝑎𝑝𝑝𝑒𝑑 
𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑐𝑎𝑓𝑓𝑒𝑖𝑛𝑒
× 100         (1) 
2.2.2.11. In-vitro gastrointestinal digestion 
2.2.2.11.1. Gastric digestion. The in-vitro gastric model protocol was adapted from 
Zeese, Huppertz, and Kelly (2008) and Sarkar, Goh, Singh, and Singh (2009) with some 
modifications introduced here. Simulated gastric fluid (SGF) containing 2g of NaCl and 7 
mL of HCl, without the addition of pepsin was diluted to 1 L and pH adjusted to 1.2 using 
1.0M HCl. Afterwards, 14.93 mg of pepsin enzyme was added to 7 ml of SGF and held at 
37°C with continuous shaking at 95 rpm in a temperature-controlled water bath (Grant 
OLS 200, Grant Instrument, United Kingdom) to mimic the conditions in the stomach. 
The pH and temperature were continuously monitored and controlled.  
Caffeine-loaded β-Lg nanoparticles and pure β-Lg nanoparticles separated from 14 mL 
suspensions by Ultrafiltration (UF) (as described in section 2.2.2.11) were re-dispersed 
in 14 mL of SGF. Then, 7 mL of SGF containing pepsin was added to the mixture to make 
up a final volume of 21 mL (protein: enzyme ratio 1.87:1 w/w). The mixture was then 
incubated at 37°C for up to 2h and samples were withdrawn at different time intervals 
for particle size measurement and RP-HPLC analysis. The pH of the mixture was 
maintained at 1.5 using 1M HCl. The digestion reaction was terminated by raising the pH 
to 8 with 0.1M NaOH prior to any analysis.   
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2.2.2.11.2 Gastrointestinal digestion. This method was based on a digestion protocol 
according to D. J. S. Mills et al. (2008) and Maccaferri et al. (2012) with some 
modifications. 15ml solution sample containing nanoparticles with and without caffeine 
was adjusted to pH 2 by using HCl (6M) and mixed with 2.5ml 0.1 M HCl which contained 
0.27g pepsin (protein: pepsin ratio 1:9 w/w). The solution was incubated in the 37 ℃ 
water bath and on a shaker with 95 rpm for 2 h. A 0.1 ml sample was taken for analysis 
of released caffeine by HPLC. Then the rest of the sample was mixed with 12.5ml NaHCO3 
in which 56mg pancreatin (protein: pancreatin ratio 1.07:2 w/w) (P3292, Sigma; 4UPS) 
and 0.35g bile (protein: bile ratio 1:11.7 w/w) (B 8631, Sigma) was dissolved and pH of 
the sample was adjusted to 7 using NaOH (6M). Samples were incubated for 3 h. After 
small intestinal phase incubation, samples were filtered through 0.45um filtration unit 
and analysed by HPLC to determine the caffeine release. 
2.2.2.12. Caffeine adsorption isotherm 
To describe the caffeine adsorption process to β-Lg nanoparticles and native protein, the 
experimental data were fitted to Langmuir adsorption model (Eq. (2)):  
𝑪𝒂𝒅 =
𝑪𝒂𝒅𝒎𝒂𝒙×𝒌×𝑪
𝟏+𝒌×𝑪
                                                 (2) 
Where, Cad is the caffeine adsorbed to β-Lg per protein at equilibrium (mg mg-1 protein), 
Cadmax × k is the maximum amount of caffeine absorbed to β-Lg (mg mg-1 protein), C is  
the concentration of caffeine free in solution at equilibrium (mg ml-1) and k is the 
adsorption constant (ml mg-1)  
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2.2.2.13. Calculations and Statistical Analysis  
Calculation of the net charge of β-Lg at different values of pH was performed with the 
online “protein calculator v3.4” software (http://protcalc.sourceforge.net) using the 
sequence of β-Lg. The results were statistically analysed by analysis of variance using 
IBM® SPSS® Statistics version 20.0. Means and standard deviations from at least three 
measurements carried out on two freshly prepared β-Lg nanoparticles were repeated. 
The significance level was set at 0.05. Data fitting of experimental data to models was 
performed with Solver from Excel MS Office 2013 (Microsoft Corporation, Redmond, WA, 
USA)  
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2.3. Results and Discussion                                          
2.3.1. Effect of pH, temperature and heating incubation time on β-Lg nanoparticles             
Native and heated β-Lactoglobulin (β-Lg) solutions were prepared 0.2% (w/v) and pH 
adjusted near to their isoelectric point (pH 6.0). All samples appeared to be transparent 
initially. Also there was only slight turbidity after pH adjustment in agreement with 
observation previously reported (Chanasattru, Jones, Decker, & McClements, 2009; 
Mehalebi, Nicolai, & Durand, 2008; Nicolai et al., 2011; P. Zimet & Y. D. Livney, 2009). 
High turbidity after heating at 75°C for 45 min appeared to provide a rough quantitative 
indication of protein aggregation in the system. A monodisperse particle size distribution 
was obtained consistently with particles of an average diameter of 200 nm to 300 nm. 
(See Fig. 2.1.). 
 
Figure 2.1: An example of particle size result by DLS for nanoparticle produced under 
conditions pH 6, heating at 75 oC for 45 mins. 
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2.3.1.1. Effect of pH 
Near the isoelectric point (pI) of the protein the overall charge is close to zero, therefore, 
repulsive electrostatic interactions between protein molecules will be minimised and 
their aggregation will be promoted. In particular, β-Lg aggregation close to its pI and 
under denaturing conditions was reported to produce particulate gels, which were 
composed of spherical particles (Donald, 2007). 
Here we studied the effect of a range of pH’s near and above the pI on the particle size. 
The pH of the aqueous β-Lg solution (0.2 % w/v) before pH adjustment was 6.8 ± 0.3. At 
this pH, a clear solution was obtained even after heating. This pH was further away from 
the pI therefore, strong electrostatic repulsive interactions between proteins molecules 
hindered their self-aggregation which resulted in reduced turbidity. To test the effect of 
pH on protein aggregation and formation of nanoparticles samples were incubated at 
pH close to the pI in the range of 5.7 to 6.2 (see Figure 2.2). At pH 5.7, the largest particle 
size, about 600nm, was recorded and clearly, particle size decreased with an increase in 
pH. This indicated that when the pH was close to pI, and the repulsive electrostatic forces 
between molecules were minimised, large particles could be formed. Conversely, when 
the pH was far from the pI, the repulsive electrostatic forces were too strong to promote 
aggregation, and consequently smaller particles were produced. Moreover, according to 
Tauliera and Chalikian (2001), within pH 5.7-6.2 only a slight change in its tertiary 
structure occurred but no alteration in secondary structure. Therefore, the hidden 
hydrophobic parts of β-Lg were exposed upon pH adjustment. 
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Figure 2.2: Effect of pH on the size and the net charge of protein nanoparticles. Size: 
black circles; protein charge: white circles (predicted by “protein calculator v3.4” 
software http://protcalc.sourceforge.net. Experiments were carried out in duplicates 
and mean standard deviations were 0.6-9.1 nm). 
Figure 2.2 shows the relationship between pH and particle size and protein’s net charge. 
It was concluded that to form nanoparticles with size in the range of 200 nm-350 nm, 
the pH should be strictly controlled at 5.9 to 6.2 and protein’s net charge between -5.8 
to -4.8. Small changes in pH outside this range led to small changes in the protein charge 
but dramatic changes in particle size. So these results highlighted the effect of a narrow 
range of pH close to the protein’s pI on the particle size.  
2.3.1.2. Effect of temperature 
The heating temperature was also found to have a significant effect on particle size at 
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constant protein concentration. The turbidity of β-Lg solution heated at 50-60 °C 
remained relatively low but increased steeply from 60-75 °C. Reproducible size 
measurements were difficult to obtain at 65 °C, and a bimodal distribution was obtained. 
For instance, the peak of the first distribution produced with 0.2% (w/v) β-Lg was 
recorded at 3.81 nm, and the sub-population was found at 145 nm. The first population 
was conjectured to be native β-Lg which is known to have a hydrodynamic radius of 
around 2.5 nm (Mehalebi et al., 2008). The possible reason for obtaining such population 
as explained by Bauer, Carrotta, Rischel, and Ogendal (2000) was that early aggregation 
of β-Lg is initiated only at 67.5°C. Significantly larger nanoparticles were formed at 75 °C 
than at 65 °C. This suggests that 65°C was not sufficient to induce complete β-Lg chain 
unfolding to produce nanoparticles in a consistent manner. On the other hand, at 75°C, 
a monodisperse particle size distribution was obtained consistently with particles of an 
average diameter about 200 nm-300 nm. 
The findings were in agreement with those by Mehalebi et al. (2008) and Gulseren et al. 
(2012), who found that elevated temperature could accelerate the rate of aggregation 
to produce larger nanoparticles. Overall the particle sizes reported here were in 
agreement with those reported by L. Donato, C. Schmitt, L. Bovetto, and M. Rouvet 
(2009), who had observed elongated compact aggregates smaller than 200 nm upon 
heating of 1% (w/v) β-Lg (pH 5.9) at 75°C. Also, Jones et al. (2010) had produced β-Lg 
particles (d<300 nm) with good stability to sedimentation as in this study under similar 
conditions. Giroux and Britten (2011) reported whey protein nanoparticles in the range 
of 194 nm produced at pH 5.0 using pH-cycling treatment. According to Jones et al. (2010) 
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optimal conditions for production of β-Lg nanoparticles occurred when the system was 
heated above thermal denaturation temperature of β-Lg and at a pH close to its pI which 
is in agreement with the above findings; these nanoparticles were reported to be 
irreversible protein aggregates and generally stable towards storage and pH changes. 
2.3.1.3. Heating incubation time 
Besides temperature, the heating time is another factor which has a significant effect on 
the particle size. Previous studies suggested that long heating incubation time promotes 
the formation of large aggregates. This was confirmed in the experiments carried out at 
varying heating times (15 to 75 minutes) but constant temperature, 75 °C (Figure 2.3); 
Note that although the water bath was at 75 °C, it took about 12-14 mins for the 
temperature in the dispersion to reach 75 °C. 
Particle size increased from 218 nm to 327 nm in the studied heating time range. The 
conformation structure changes might happen including the hidden hydrophobic groups 
at the central cavity and disulphate bonds exposing to the environment, and the particles 
were produced. The polydispersion index (PDI) decreased and had a minimum value at 
45mins. As shown by the low PDI number at this heating incubation time, a 
monodispersion was obtained. 
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.   
Figure 2.3: β-Lg nanoparticle size for continuing heating incubation (15minutes-
75mintues). ◆The β-Lg nanoparticles size; ■ PDI of nanoparticles. 
In summary, both heat load (combination of temperature and time) and pH were found 
to be the key operating parameters at constant protein concentration in the production 
of nanoparticles of a given size. The β-Lg nanoparticles in the range of 200-300 nm were 
obtained in a consistent and reproducible manner by inducing heat denaturation and 
aggregation of the protein in an aqueous solution at 0.2%, pH 6.0 and 75 °C for 45 
minutes. At these conditions, a monodisperse size distribution was obtained and with 
good reproducibility.  
Protein aggregation may occur due to covalent and non-covalent interactions between 
unfolded protein molecules. As protein denatures, it will unfold to expose the 
hydrophobic groups as well as the reactive thiol group at Cys 121, which leads to protein 
molecules interacting via non-covalent interactions (hydrophobic interaction, hydrogen 
bonding) and covalent interactions (disulphide bonds) to form particles of a given 
microstructure.(L. Donato et al., 2009; Havea, Singh, & L.K., 2001) In order to obtain an 
PDI 
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insight into the physical characteristics of the nanoparticles and their microstructure, the 
following characterisation study was carried out. 
2.3.2. Characterisation of β-Lg nanoparticles 
2.3.2.1 Stability to dissociating buffers  
In order to get an insight into the type of the microstructure formed and the main 
interactions governing its formation, the stability of the particles to several buffers was 
investigated. All samples were filtered by 0.45 μm filter before the incubation with 
dissociation buffers. The effect of dissociating buffers was determined based on changes 
in particle size (Table 2.1). 
Table 2.1: Effect of dissociating buffers on nanoparticle diameter (nm). The incubation 
time with dissociating buffers was 60 minutes. 
Treatment Before 
incubation 
10M Urea 1%(W/V) 
SDS 
0.1 M 
2-Mercap-toethanol 
0.1 M DTT 
 
Particle size 173.0±12.5 a 234.2±1.9b 17.41±8.8c 176.5±0.6a 186.1±1.5 a 
Experiments were carried out in duplicate, mean values with different superscript letters are 
significantly different at p < 0.05, the particle size before incubation is lower than 200 nm due to the 
filtration of 0.45 mm filter. 
 
Sodium dodecyl sulphate (SDS) interacts with proteins via electrostatic interactions and 
hydrophobic interactions while keeping covalent bonds intact (Reynolds & Tanford, 1970; 
Roy, Kumar, & Gurusubramanian, 2012). A significant reduction in particle size was 
observed which demonstrates that hydrophobic interactions are essential to the 
stabilisation of the microstructure of these particles.  
Urea is a very powerful protein denaturant with the ability to break hydrogen bonds. It 
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is considered that urea acts by breaking down protein hydrogen bonds as it interacts 
with peptide groups in unfolded proteins by hydrogen bonding. Interestingly, most β-Lg 
nanoparticles were not disrupted by urea. On the contrary, the particle size increased 
significantly as demonstrated. The swelling of the nanoparticles could be due to the 
formation of hydrogen bonds with the water molecules within the particles (Huppertz & 
de Kruif, 2008). These results demonstrated the presence of hydrogen bonds within the 
internal structure of β-Lg nanoparticles. 
2-Mercaptoethanol was added to β-Lg nanoparticle dispersions to cleave disulphide 
bonds. Interestingly, 2-Mercaptoethanol had no significant effect on the size of the 
nanoparticles, therefore, disulphide bonds were not responsible for the microstructure 
formation. In order to confirm the above results, another dissociating buffer, 0.1 M 
Dithiothreitol (DTT), was used. DTT is a dissociating buffer, which disrupts disulphide 
bonds. The nanoparticles were stable during incubation with DTT for 60 min and even 
after one day (data not shown here). These results confirmed that disulphide bonds were 
not mainly responsible for the microstructure formation. Various authors (Alting, Hamer, 
de Kruif, Paques, & Visschers, 2003; H. J. Giroux et al., 2010; S. Ko & S. Gunasekaran, 
2006; Mudgal, Daubert, & Foegeding, 2011; Nicolai et al., 2011) have demonstrated the 
significant role of thiol-disulphide reactions in β-Lg aggregation but the reaction was 
shown to be favoured at neutral to alkaline pHs. In addition, Alting et al. (Alting et al., 
2003) had further ascertained the fact that disulphide bonds did not significantly 
contribute to the acid-induced aggregation of diluted solutions of whey protein in the 
initial stage of aggregation. However, partially cross-linked disulphide bonds were found 
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in protein gels kept for a period of time, namely ageing period (Alting et al., 2003; H. J. 
Giroux et al., 2010; Nicolai et al., 2011). Alting et al. (2003) demonstrated that the 
formation of disulphide cross-linking was strongly affected by the pH (at pH 5 only 1:3160 
sulphur groups is deprotonated and able to initiate thiol/disulphide exchange reactions) 
and protein concentration (4.5% initial protein concentration was identified as the 
critical value below which no significant crosslinking may occur). Since the β-Lg 
nanoparticles produced in this study did not undergo the aforementioned ageing period 
and the pH and protein concentrations were not favourable to disulphide cross-linking, 
it is reasonable to conclude that disulphide bonds did not actively participate in the 
formation of the microstructure of the nanoparticles produced in the current study.  
In summary, the predominant interactions responsible for the microstructure of the 
nanoparticles were found to be hydrogen bonding and hydrophobic interactions. 
Increased hydrogen bonding induces the formation of β-sheets in a protein which, is 
commonly found in aggregates (Gunasekaran et al., 2006). Hydrophobic interactions also 
played a major role in the aggregation process of β-Lg as expected since this protein has 
significant portions of hydrophobic patches, with the exact effective hydrophobicity 
reported to be 12.2 (Gunasekaran et al., 2006; Hansted, Wejse, Bertelsen, & Otzen, 2011; 
S. Ko & S. Gunasekaran, 2006) and upon denaturation this area will be further exposed.  
2.3.2.2. Microscope image of nanoparticle 
To further characterise the microstructure of β-Lg nanoparticles, environmental 
scanning electron microscopy was carried out on samples produced at the optimum 
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conditions (described in 2.2.2.5.).  
 
Figure 2.4: The ESEM image of β-Lg nanoparticles. 
The ESEM image in Figure 2.4 showed spherical aggregates and in the range of sizes of 
those measured by DLS. This was in agreement with Krebs et al (Krebs, Devlin, & Donald, 
2009) who reported the formation of spherical aggregates at the pH close to protein’s pI.  
Moreover, the zeta potential of these nanoparticles was determined as the key indicator 
of the stability of colloidal dispersions. The zeta potential of the β-Lg dispersion was     
-37.42±2.93 mV, which indicated a moderate stable colloidal system.  
2.3.2.3 Yield of aggregation of β-Lg 
In preliminary filtration experiments with an aqueous solution of β-Lg and a 50 KDa 
ultrafiltration membrane, it was shown that any non-aggregated β-Lg permeated 
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through the ultrafiltration membrane and thus the aggregation yield was determined 
based on the determination of protein concentration in the permeate by using 
bicinchoninic acid (BCA) method as described in 2.2.2.4. Nearly 93% of β-Lg aggregated 
when heated at 75 °C for 45 min. These aggregation yields were similar to those reported 
by others at higher heat loads (L. Donato et al., 2009; H. J. Giroux et al., 2010; Moitzi et 
al., 2011; Mudgal et al., 2011; Schokker, Singh, Pinder, & Creamer, 2000); Giroux et al. (H. 
J. Giroux et al., 2010) reported an aggregation yield of 97.3% after heating 1% (w/v) whey 
protein dispersion at 80°C for 15 min. 
2.3.2.4. β-lactoglobulin conformational changes by fluorescence spectroscopy 
The β-Lg contains two Trp residues, Trp19 and Trp61: Trp19 is within the cavity of β-Lg 
whereas Trp61 is located at the surface of the protein molecule and is close to the Cys66-
Cys160 disulfide bridge (B. Y. Qin, M. C. Bewley, et al., 1998; Qin, Creamer, Baker, & 
Jameson, 1998). The X-ray crystallographic image also illustrated that Trp19 is located in 
the interior of the β-Lg molecule, which is the major binding point of β-Lg (L. Sawyer, 
2002). A mutant β-Lg molecule study helped to prove that Trp19 was a major fluorophore 
of β-Lg in the non-polar environment (Creamer, 1995). By the influence of heat, the 
conformation changed at about 50 °C, one of the tryptophan was transferred to a more 
polar environment accessible to solvent and above 70°C the second tryptophan residue 
became exposed to solvent. But even at 90°C, the second one was partially buried (O. E. 
Mills, 1976). Therefore in order to investigate conformational changes in β-Lg after heat 
denaturation and after caffeine encapsulation, the fluorescence emission spectra of 
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tryptophan was measured (Figure 2.5). An increase in the fluorescence intensity was 
observed for β-Lg nanoparticles and a fluorescence quenching effect by the caffeine 
upon binding to the nanoparticles. The increase in fluorescence intensity can be 
explained based on the exposure of previously buried Trp groups upon heating induced 
conformational changes in the protein. 
 
 
Figure 2.5: The fluorescence emission changes of native β-Lg, β-Lg nanoparticles and 
caffeine-loaded β-Lg nanoparticles. 
2.3.2.5. Mechanism of nanoparticle formation 
Based on previous studies on β-Lg and our observations above the following mechanism 
of nanoparticle formation is proposed. At neutral pH, β-Lg exists as dimer in aqueous 
solution. Upon pH adjustment (to pH 6) and heating the dimer dissociates and denatures 
to reactive monomers. Protein molecules start to unfold, and hydrophobic groups are 
exposed (as shown by fluorescence measurements) which promote intermolecular non-
covalent interactions (hydrophobic interactions, and hydrogen bonding) to form 
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particles of a given microstructure as demonstrated by the stability to buffers. Although 
at these denaturing conditions, the reactive thiol group in the protein would get exposed 
the pH and protein concentration conditions (and lack of ageing time) used in this study 
did not lead to the formation of disulphide bonds and subsequent cross-linked gel-like 
structure. Moreover, the spherical aggregates (as visualised by ESEM) had a good 
colloidal stability which was supported by an overall strong negative charge (-37.42±2.93 
mV) measured as zeta-potential. 
2.3.3. Yield of caffeine encapsulation 
The yield of caffeine encapsulation increased when caffeine to β-Lg molar ratio increased 
reaching a maximum 13.54% at a molar ratio of 50 (mass ratio caffeine to ß-Lg 1:2) (Table 
2.2). Above this maximum, a slow reduction of the percentage of caffeine encapsulation 
was observed for higher caffeine to β-Lg molar ratio values. In addition, caffeine-loaded 
particles were significantly larger than those without caffeine (over 350 nm). Li et al. (B. 
Li, Du, Jin, & Du, 2012) and Shpingelman et al. (A. Shpigelman, Y. Cohen, & Y. D. Livney, 
2012) had also found a similar trend for their EGCG (epigallocathechin-3-gal-late)-loaded 
β-Lg nanoparticles. 
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Table 2.2: Caffeine encapsulation by β-Lg nanoparticles. (All the encapsulation 
efficiency results are the average of three replicates) 
Caffeine to β-Lg 
molecular ratio 
10:1 20:1 50:1 100:1 200:1 
Encapsulation 
efficiency (%) 
10.25±1.2b 11.68±3.0 a 13.54±3.3 a 10.07±2.0 c 9.73±0.2 d 
Particle size (nm) 374.1±5.1a 366.5±4.7 b 381.7±1.7c 359.6±3.0d 356.0±2.6d 
Experiments were carried out in triplicate, mean values with different superscript letters are 
significantly different at p < 0.05 
 
The same results were plotted as an adsorption isotherm (Figure 2.6) as it was 
hypothesised that caffeine bound (adsorbed) the exterior of the nanoparticles up to 
reaching equilibrium concentration. Interestingly it was found that the equilibrium 
concentrations of caffeine bound (measured as caffeine mass per protein mass) and 
caffeine free in solution followed a Langmuir type isotherm. Parameters of adjustment 
of experimental data to Langmuir model were shown in Table 2.3  
Table 2.3: Adjustment of caffeine adsorption to Langmuir model.  
 Native β-Lg β-Lg nanoparticles 
Cad max 0.103 mg/mg protein 0.263 mg/mg protein 
k 1.194 ml/mg 0.423 ml/mg 
r2 0.96332 0.96244 
 
In the case of nanoparticles, a maximum binding capacity of 0.205 mg caffeine per mg 
β-Lg was found which means 19.4 molecules of caffeine per protein. However, when the 
same experiments were conducted with native β-Lg the maximum binding capacity was 
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only 0.084 mg caffeine per mg protein. Additionally, caffeine showed three times more 
affinity for partially denatured β-Lg in nanoparticles than for native protein.  
This clearly showed that the conformational change induced in the protein due to heat 
denaturation led to an increase in binding capacity.  
 
Figure 2.6: Isotherm of caffeine encapsulation of native β-Lg (white circles) and the  
β-Lg nanoparticles (black circles). Lines represent adjustment to Langmuir model.(. 
Each of these experiments did in duplicate. For β-Lg nanoparticles (black circles), 
Standard deviations of Caffeine bound was 0.000116-0.000915 mg/mg protein. 
Standard deviations of Caffeine free in solution was 0.000466-0.010735mg/ml. For 
native β-Lg (white circles), Standard deviations of Caffeine bound was 0.001437-
0.017185 mg/mg protein. Standard deviations for Caffeine free in solution was 
0.001437-0.0017185 mg/ml).  
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2.3.4. Simulated gastric digestion 
The in-vitro experiment was carried out by suspending the nanoparticles containing 
caffeine in simulated gastric fluid (SGF) with pepsin for 120 min under continuous 
shaking at 37°C. Conditions of temperature and pH were set equivalent to the normal 
gastric digestion conditions (A. Shpigelman et al., 2012). The protein: enzyme ratio 
(1.875:1) used here was similar ratio to that reported in other works (L. Chen & M. 
Subirade, 2005; Sarkar et al., 2009; A. Shpigelman et al., 2012; Zeese et al., 2008). It is 
important to note that optimal ratio that suits the exact physiological secretion in 
humans was extremely hard to establish due to the variation in gastric secretions in 
different individual’s health conditions and food choice (Sarkar et al., 2009). Various 
protein: enzyme ratio had been proposed by Kibatake and Kinekawa (1998), Zeese et al. 
(2008), Sarkar et al. (2009), and A. Shpigelman et al. (2012), but all the authors claimed 
that complete hydrolysis of β-Lg was not achievable at any given pepsin concentration. 
Therefore, this ratio was chosen here to expose β-Lg nanoparticles to more extreme 
gastric conditions.  
Upon addition to SGF, the pH of the β-Lg dispersions dropped immediately to around 
~1.5 to mimic the empty stomach pH and to provide the optimum conditions for 
hydrolysis by pepsin. Rapid decay of particle size was observed (Figure 2.7) and during 
the incubation period polydispersity increased which can be a consequence of the 
unspecific action of pepsin on the peptide bonds.  
So particle degradation happened in the first 2 minutes. At this time particle size reduced 
to 5 nm which corresponds to the average size of a protein dimer (Nicolai et al., 2011; 
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Sakurai, Oobatake, & Goto, 2001) and the size remained to less than 10 nm with no 
significant difference for 60 minutes (Figure 2.7).  
High Burst effect was observed in the kinetics of caffeine release revealing a common 
problem in the development of controlled release formulations when low molecular 
weight compounds are loaded into nanoparticles. This Burst effect seems related to the 
rapid nanoparticle degradation. In spite of this, high amounts of caffeine were retained 
in the nanoparticle (68.14% at 2 minutes) and slow and little release of entrapped 
caffeine was noted, even at the end of incubation (36.40%). 
 
Figure 2.7: The release of caffeine and changes of nanoparticles size under SGF. Black 
circles: Caffeine release percentage under SGF condition. White circles: Stability of β-
Lg nanoparticles SGF condition. (Each of these experiments did in duplicate with 
standard deviations 2.21-3.19% for release and for size 0.80-2.33 nm). 
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Moreover, the gastric digestion applied in the gastrointestinal digestion experiments, 
where lower protein to pepsin ratio was used (1:9) than in the gastric digestion 
experiments (1.87:1) (see Methods), led to similar results, 36.71% caffeine released. 
Furthermore, almost all the caffeine was released after the small intestinal digestion 
phase (99.22%). Our results agreed with those of A. Shpigelman et al. (2012) as their β-
Lg-EGCG complex managed to preserve 79% of their contents after 180 min of 
incubation in 1:20 pepsin: protein ratio solution. 
The fact that most of the caffeine was still bound to the protein after the microstructure 
has been destroyed indicates that the binding of the caffeine to protein was not so 
dependent on the microstructure but on the protein conformation and the 
establishment of interactions (most probably hydrophobic and hydrogen bonds) 
between the protein molecule and the caffeine.  
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2.4. Conclusion 
One of the main outcomes of this study is that we have developed a simple method that 
relies on the heat denaturation of β-Lg and leads to the consistent production of 
nanoparticles of given size (average diameter 200-300 nm) and characteristics with 
colloidal stability and high yield of aggregation (>93%) at the optimum conditions of pH 
(6.0) and heat load (heating at 75 °C for 45 mins), which were found to be the key 
operating parameters. The characterisation of the nanoparticles by a range of 
techniques including fluorescence, DLS, and microscopy in combination with the 
measurement of their stability to buffers led to an improved insight of their formation 
and their microstructure at the optimum conditions. In summary, heat denaturation led 
to the protein unfolding, exposure of hydrophobic regions and subsequent formation of 
protein aggregates by non-covalent intermolecular interactions. 
Maximum encapsulation efficiency of caffeine was 13.54% at 50:1 caffeine to β-Lg molar 
ratio. Caffeine-β-Lg nanoparticles (~350 nm) were found significantly larger than pure β-
Lg nanoparticles (~250 nm). Heating of β-Lg unfolded the non-polar region in the protein 
and led to an increase in binding of caffeine as compared to native β-Lg. Interestingly，
the binding of caffeine to protein followed a Langmuir type isotherm. Both pure β-Lg and 
caffeine loaded β-Lg nanoparticles exhibited rapid peptic degradation, but only 36.4% 
caffeine was released under these conditions and complete release at intestinal 
conditions, hence suggesting improved enteric delivery. Furthermore, both the fitting of 
the experimental results to a binding isotherm and the low release of caffeine even when 
complete disruption of the microstructure occurred suggest that caffeine binds to the 
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unfolded protein molecule at a maximum ratio of 19 molecules of caffeine per molecule 
of protein. Overall the encapsulation efficiency was slightly better than that obtained 
with liposomes nanoparticles (3.8% to 9.7%) produced by Pham, Jaafar-Maalej, 
Charcosset, and Fessi (2012) utilising phospholipid and cholesterol and less than that 
obtained with niosomes particles produced from cholesterol and surfactant (30.4%) by 
Khazaeli, Pardakhty, and Shoorabi (2007) but with significantly larger vesicle sizes (6-
22μm). Spontaneous binding of caffeine to β-Lg nanoparticles could open the 
opportunity for the application of this milk protein as a molecular nano-vehicle to 
manufacture products fortified with caffeine without intense bitterness that may 
interfere with the original product flavour. Other potential applications include the 
binding of bioactives to improve their solubility and/or bioavailability. 
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CHAPTER THREE                                             
Characterisation of resveratrol-β-lactoglobulin nanoparticles and thermal stability  
ABSTRACT  
Resveratrol, a phenolic antioxidant which widely distributed in many plants, is proved to 
exhibits many health benefits properties such as anti-inflammatory, antioxidant and 
antimicrobial activities. However, low solubility and instability of resveratrol are main 
impediments to achieve its bioavailability. Beta-lactoglobulin (ß-Lg), the major whey 
protein, is believed to play an important role to transport small hydrophobic molecules. 
The solubility of resveratrol was determined as 5-7mg/100ml by total phenolic content 
(spectrophotometric and Folin method). Production of resveratrol-beta-lactoglobulin 
nanoparticles was produced according to the method (pH 6 and 75°C, 45 min) developed 
by the previous study. The size of resveratrol-ß-Lg nanocomplexes was 181.8 nm, and 
the concentration of resveratrol had no influence on the size of nanoparticles. During 
heating, a thermal degradation and isomerization happened, and resveratrol-ß-Lg 
nanoparticles exhibited an improved antioxidant activity even though the fluorescence 
measurement confirmed that native ß-Lg have stronger binding ability than 
nanoparticles form. The binding of resveratrol and native ß-Lg was following a Stern-
Volmer model; binding constant was 1.67х105, and the binding number is 1.33. No 
binding model was found to fit Resveratrol-ß-Lg nanoparticles. Resveratrol-ß-Lg 
nanoparticles maintained the antioxidant activity level under Pasteurisation. Therefore, 
Beta-lactoglobulin has the potential to protect the antioxidative properties of 
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resveratrol under thermal processing and could be utilised for food applications.  
Keywords: Resveratrol, Beta-lactoglobulin, Nanoparticles, Antioxidant activity. 
3.1. Introduction 
Nowadays, consumers are attracted to dietary supplements instead of drugs to improve 
health and oral administration is the most convenient and commonly applied method 
to develop new nutraceutical. Based on many studies, the predominant problem of 
nutraceuticals is poor bioavailability due to their low aqueous solubility which, affects 
over 40% of the new chemical entities produced by high throughput screening processes 
(Lipinski, 2002). Several reasons contribute to the solubility problem: 1) high Molecular 
weight; 2) high Log of the octanol-water partition coefficient (log P), which is a measure 
of a drug's lipophilicity. In order to improve the aqueous solubility, numerous researchers 
have developed many approaches such as particle size reduction, crystal engineering, 
salt formation, solid dispersion and use of surfactant, complexation (Savjani, Gajjar., & 
Savjani, 2012). New techniques like nanoparticles, nanotubes, nanosuspensions and 
nanocomplexes are employed to improve the solubility of poorly soluble drugs and 
nutraceuticals (Rabinow, 2004; Tran, Tran, & Lee, 2013). Proteins like zein, whey proteins, 
soy proteins and other natural polymers like cyclodextrins have been applied not only in 
pharmaceutical but also in food applications (Duarte et al., 2015; Gorji et al., 2015; 
Pujara, Jambhrunkar, Wong, McGuckin, & Popat, 2017). Empirically, the nutraceuticals 
have similar benefits as pharmaceuticals but without all of the side effects. Therefore, 
in the food industry, the concept of “General Recognised As Safe” (GRAS) has been 
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applied to nutraceuticals supplements since 1958 (Burdocka & Carabin, 2004). Simple 
and safe carrier candidates, which meet the GRAS qualification and possibly have 
essential health benefits, should be investigated to improve aqueous solubility of 
bioactives.   
 
Figure 3.1: the chemical structure of Trans-Resveratrol and cis- Resveratrol (Burns et 
al., 2002). 
Resveratrol (3,5,4'-Trihydroxystilbene), is a typical non-flavonoid phenol that belongs to 
the stilbene family and has various properties including antioxidant, anti-cancer, anti-
inflammatory, and antineoplastic (Bhat & Pezzuto, 2002; Jang et al., 1997; Soleas, 
Diamandis, & Goldberg, 1997). Resveratrol is thought to be one of the main contributors 
to the famous “French paradox”: despite the French people’s high-fat intake, a low 
cardiovascular diseases incidence was found. It has been ascribed partly to the red wine 
consumption (Catalgol, Batirel, Taga, & Ozer, 2012). Since then, the studies of 
resveratrol have been carried out broadly in the food and pharmacy field. There are 72 
different natural resources which contain resveratrol, especially grapes, peanuts and 
blueberries (Burns et al., 2002; Jimenez-Garcia et al., 2012; Limmongkon et al., 2017; 
Lyons et al., 2003). Even though resveratrol is widely distributed in various plants and 
Yuchen Guo                                                                         Chapter Three                                                                                              
78 
  
fruits, there are some pharmacokinetic limitations, which led to low bioavailability: The 
low water solubility, labile properties, and rapid metabolism (Amri, Chaumeil, Sfar, & 
Charrueau, 2012; Database, 2017; Pund, Joshi, & Patravale, 2016). The low solubility of 
resveratrol in oral administration is due to the chemical structure of resveratrol: two 
phenolic rings bonded together by a double styrene bond, which contributes two 
isometric cis- and trans-forms of resveratrol (Figure 3.1) (Gambini et al., 2015). It is 
believed that the trans-isomeric form is more abundant than cis-resveratrol, while the 
trans-isomer is able to transform into cis-isomer under light exposure and heating. Light 
exposure allows a rapid isomerization of trans-resveratrol, especially in the ultraviolet 
radiation at 366nm or at low concentration (Flieger, Tatarczak-Michalewska, & 
Blicharska, 2017; Frkmont, 2000; Gambini et al., 2015; Trela & Waterhouse, 1996). 
Heating not only leads to increasing of solubility but also results in degradation, 
isomerization and reduction of antioxidant activity. The effect of heating on resveratrol 
can be complex depending on temperature (Flieger et al., 2017; Lee et al., 2014). In 
order to overcome its low solubility and low stability hence to achieve bioavailability, 
encapsulation might be a solution to handle these limitations of resveratrol. The 
encapsulation of resveratrol with a number of biopolymers has been investigated 
including chitosan and γ-poly (Jeon, Lee, & Lee, 2016), soy protein isolate (Pujara et al., 
2017), milk protein (Gorji et al., 2015) and zein (Penalva et al., 2015) and β-lactoglobulin 
(Zhang et al., 2014). The main whey protein, β-lactoglobulin, plays an interesting role in 
transporting retinol molecules and has binding properties of small hydrophobic 
molecules. Resveratrol has been found to be bound to the surface of the hydrophobic 
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pocket of β-lactoglobulin (Liang & Subirade, 2010; Liang, Tajmir-Riahi, & Subirade, 2008). 
Thus, β-lactoglobulin can be an attractive candidate as a carrier to offer a solution to 
both, poor solubility and low stability to processing /storage conditions such as heating 
and light exposure. 
In Chapter two, β-lactoglobulin nanoparticles were found to complex with caffeine (Guo, 
Harris, Kaur, Pastrana, & Jauregi, 2017). Higher binding affinity for caffeine in 
nanoparticles form rather than in the native form was found. The aim of the present 
work is to apply this method to produce resveratrol-β-lactoglobulin nanoparticles, 
investigate the effect of these nanoparticles and native β-lactoglobulin on the solubility 
and stability of resveratrol under different thermal processing conditions. In addition, 
fluorescence measurements were carried out to gain an insight into the interactions 
between these two molecules. Moreover, the stability of resveratrol to light is 
investigated. The results of this study might be useful in the investigation of future 
carriers for stabilisation and delivery of resveratrol. 
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3.2. Materials and methods  
3.2.1. Material 
98% w/w trans-resveratrol is supplied by HPLC from Evolva RES140332   
β-Lactoglobulin from bovine milk ≥ 85.0 % (PAGE), lyophilized powder L2506 is 
purchased from Sigma 
Folin-Ciocalteu reagents: Folin-Ciocalteu (F9252), and Sodium carbonate BioXtra,≥99.0% 
(S7795) is purchased from Sigma 
Reagents of ABTS method: 2,2’-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) 
diammonium salt (ABTS) ≥98.0 % (HPLC) (A1888), Potassium persulfate (K2S2O8) ACS 
reagent, ≥99.0% (216224)；(±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic 
acid (Trolox), 97%  (238813),  and ethanol, ≥99.8% (GC) (32221) are purchased from 
Sigma-Aldrich  
Reagents of the ferric reducing antioxidant power (Frap) method reagents： 
TPTZ (2,4,6-Tris(2-pyridyl)-s-triazine) (T1253)；Ferric Chloride Hexahydrate(207926) are 
purchased from Sigma-Aldrich. 
3.2.2. Determination of resveratrol solubility in water solution  
A series of resveratrol solutions/suspensions were prepared from 1mg/100ml, 
3mg/100ml, 5mg/100ml, 7mg/100ml, 8mg/100ml, and 9ml/100ml to determine the 
solubility of resveratrol. All the solutions/suspensions were covered by tissue paper and 
were stirring with a magnetic stirrer at room temperature for 2 hours before any 
measurements. Two methods were applied to determine resveratrol solubility in water 
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solution: the direct spectrophotometric method and total phenolic content by Folin-
Ciocalteu method. 
The direct spectrophotometric method: The Lambda max value of resveratrol aqueous 
solution (2mg/100ml) was determined by using a Lambda 20 spectrophotometer 
(Perkin-Elmer®) and scanning UV absorption from wavelength 190nm to 600nm with 1 
nm spectral bandwidth. The absorbance of resveratrol solutions/suspensions was 
measured at the maximum wavelength by the Spectrophotometers (Ultrospec ® 1100 
pro) using a quartz cuvette with a path length of 1cm and deionized water was used as 
the blank. The solubility of resveratrol at room temperature was determined from the 
plot of the absorbance against concentration as the concentration after which no further 
significant increases were observed.  
Folin-Ciocalteu method: The total phenolic content of all concentrations of resveratrol 
solutions/suspensions was measured by Folin- Ciocalteu method at 760nm, which was 
adapted from L.Singleton, Orthofer, and M.Lamuela-Raventós (1999). In general, 0.2 ml 
of resveratrol solution was added to around 6.0ml of deionized water into a 10ml 
volumetric flask. Folin-Ciocalteu reagent (0.5ml) was added and mixed. After 1 minute 
and no longer than 8 minutes, 1.5 ml 20% sodium carbonate solution was added and the 
volume adjusted to 10ml. After 2 hours incubation in the dark, the absorbance was 
recorded at 760nm using a UV-Vis Spectrophotometer (Ultrospec ® 1100 pro). Deionised 
water was used as the blank. All the experiments were carried out in triplicates, and the 
results were expressed in gallic acid equivalents (GAE; mg/L) using a gallic acid (10-
120mg/L) standard curve. The solubility of resveratrol was determined as the 
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concentration at which the GAE value reached a peak and remained constant afterwards.  
3.2.3. The stability to light of Resveratrol standard solutions  
Resveratrol solutions/suspensions were exposed to overhead light (Philips, TL-D 840, 
70w, and distant was 1 meter) in the laboratory during 0, 1, 3, 6 and 12 hours. The total 
phenolic content was measured at 303nm by a spectrophotometer (Ultrospec ® 1100 
pro) and the Folin-Ciocalteu method as described above. The total antioxidant capacity 
of samples was measured by ABTS as described above. All the samples were determined 
in duplicate. 
3.2.4. The preparation of resveratrol-β-lactoglobulin nanoparticles 
Native β-lactoglobulin powder (0.01g) was added into 5ml resveratrol standard 
solutions /suspensions of varying concentrations in a 7ml Sterile container. Then the pH 
of the sample was adjusted to 6.0 using a pH meter (Mettler Toledo, Switzerland) with 
0.1M HCl and 0.1M NaOH. After this, the sample was introduced into a water bath 
(Grant Instrument Ltd., Cambridge, United Kingdom) that have been previously heated 
at 75 °C. The sample was kept for 45 minutes at this temperature; it must be noted that 
the temperature of the sample reached the set temperature after about 13 minutes. On 
completion of the incubation time, samples were transferred to an ice bath for 10 
minutes to terminate incubation. After 10 minutes in the ice bath, the pH of the sample 
was measured. The particle size was determined by dynamic light scattering (DLS). 
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3.2.5. The effect of heating and native β-lactoglobulin and β-lactoglobulin nanoparticle 
on the stability of resveratrol 
After determination of solubility of resveratrol, all the following studies were carried out 
in a range of concentrations of resveratrol at the solubility or below. A set of resveratrol 
aqueous solutions in the range of solubility were used as a control and compared against 
samples of the same concentration of resveratrol that underwent different treatments. 
There were three different treatments: heating (see details below), the addition of 
native β-lactoglobulin (details below) and β-lactoglobulin nanoparticles (in 3.2.3). 
When studying the effect of heating, all varying concentrations of resveratrol 
solutions/suspensions were heated at 75°C in a water-bath for 45 minutes and moved 
to an ice bath for 10 minutes afterwards. Then, samples were taken for analysis. 
When exploring the effect of adding native β-lactoglobulin, 0.01g native β-lactoglobulin 
powder was added to 5ml resveratrol standard solutions/suspensions of varying 
concentrations in a 7ml Sterile container. Then samples were ready to carry out the 
further study.   
The effect of heating, adding native β-lactoglobulin and β-lactoglobulin nanoparticles on 
the stability of resveratrol were determined by total phenolic content and the total 
antioxidant activity. For the total phenolic content, the Folin-Ciocalteu method 
mentioned above was applied, and when measuring the samples with native β-
Lactoglobulin and β-Lactoglobulin nanoparticles, the interference of protein was 
eliminated by subtracting the GAE value of protein from the GAE value of samples. All 
the samples were prepared and determined in duplicate. 
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For the total antioxidant activity, the [2,2’-Azinobis(3-Ethylbenzothiazoline-6-Sulphonic 
Acid)] (ABTS) Free Radical Scavenging Activity Assay and Ferric ion Reducing 
Antioxidant Power assay (Frap) were used. In detail: 
ABTS method: The total antioxidant activity of all samples was measured by ABTS assay 
at 734nm, which was modified from Re et al. (1999). In general, the ABTS•+ stock solution 
was prepared by mixing solution 5ml ABTS solution (7mM, 50ml volume, stored in an 
amber flask and kept under refrigeration at 0-4°C up to one month) and 88μl Potassium 
Persulfate (K2S2O8) solution (140mM, 10ml volume, stored in an amber flask and dark 
place at room temperature up to one month) together. Then the mixture was kept in 
the dark and room temperature for at least 16h prior to use. For the study of phenolic 
compounds, the working solution of the ABTS•+ was obtained by diluting the ABTS•+ 
stock solution with phosphate buffered saline (PBS pH 7.4) to an absorbance of 
0.70±0.02 at 734nm. 20μl of samples was added into 2ml ABTS•+ working solution, and 
the mixture was homogenised by 1mins vortex. The mixture was then incubated in the 
dark for 6 minutes, and the absorbance (ABSsample) was recorded at 734nm using a UV-
Vis Spectrophotometers (Ultrospec ® 1100 pro). The absorbance of ABTS•+ working 
solution was measured at the same wavelength and used as control (ABScontrol). The PBS 
was to blank the spectrophotometer. The percentage of scavenging activity of each 
sample on ABTS•+ was calculated as the inhibition% (I%) using the following equation 
(Shah & Modi, 2015): Eq.(1) 
𝐈% =
(𝐀𝐁𝐒𝐜𝐨𝐧𝐭𝐫𝐨𝐥− 𝐀𝐁𝐒𝐬𝐚𝐦𝐩𝐥𝐞)
𝐀𝐁𝐒𝐜𝐨𝐧𝐭𝐫𝐨𝐥
× 𝟏𝟎𝟎                                         (1) 
When measuring the samples with native β-Lactoglobulin and β-Lactoglobulin 
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nanoparticles, the interference of protein was eliminated by subtracting the I% of 
protein from the I% of samples. All the samples were prepared and determined in 
duplicate. 
Frap method: The total antioxidant activity of all samples was also assessed by Frap 
method at 595nm, which was modified from Benzie and Strain (1996).In principle, The 
stock solution of Frap method included: 300 mM Acetate buffer (pH 3.6, 2.699 g sodium 
acetate trihydrate and 16ml (16.8g) glacial acetic acid dissolved in 1L deionised water), 
2,4,6-tripyridyl-s-triazine (TPTZ) (10mM) in 10ml HCl (40mM), and 20mM Ferric Chloride 
Hexahydrate aqueous solution. The Frap reagent was mixed with the 25ml Acetate 
buffer, 2.5ml TPTZ and 2.5ml Ferric chloride solutions. Then ten μl of the 
sample/standard was added into 300μl Frap reagent in a microcentrifuge tube and 
vortexed for 10 seconds. Then 100μl of this mixture, in triplicates, was transferred into 
the microwell plate (96well, NUNC, FB) and absorbance was measured at 595nm by a 
computer controlled Tecan Microplate reader. Results were express as the ascorbic acid 
equivalents (AAE) using an ascorbic acid (0.001761mg/ml-0.1761mg/ml) standard curve. 
Increased absorbance of the reaction mixture indicated greater reduction capability. 
When measuring the samples with native β-Lactoglobulin and β-Lactoglobulin 
nanoparticles, the interference of protein was eliminated by subtracting the AAE value 
of protein from the AAE value of samples. All the samples were prepared and 
determined in triplicate. 
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3.2.6. The protective effects of native β-lactoglobulin and β-lactoglobulin nanoparticle 
on resveratrol under pasteurisation condition 
Different concentrations of resveratrol standard solutions/suspensions, resveratrol-
native β-lactoglobulin solutions and resveratrol-β-lactoglobulin nanoparticles solutions 
prepared using the methods above were incubated at Pasteurisation conditions, 63°C 
for 30 minutes. Then the total phenolic content was determined by Folin-Ciocalteu 
method. The total antioxidant capacity of samples was measured by the ABTS method. 
All the samples were determined in duplicate. 
3.2.7. Fluorescence measurement of resveratrol-β-lactoglobulin solutions 
The concentrations of resveratrol solutions were 0.23mg/100ml, 0.46mg/100ml, 
0.92mg/100ml, 1.84mg/100ml, and 2.48mg/100ml.The protein concentration of 
resveratrol-native β-Lg solutions and resveratrol-β-Lg nanoparticles solutions was kept 
constant at 0.2% w/v. The degree of β-Lg conformational changes was determined 
based on fluorescence emission of tryptophan (Trp), which was measured by 
fluorescence spectrophotometer with the temperature controller (Varian Cary Eclipse, 
United Kingdom). Fluorescence spectra were obtained after excitation at 295nm, 
scanning an emission wavelength range between 300 nm to 510 nm, using 5nm 
excitation and emission slits wavelength. The data was collected by Cary Eclipse 
software version 2 (Varian Cary Eclipse, United Kingdom) and samples were analysed in 
at a constant temperature of 20°C. According to Liang and Subirade (2012), the 
fractional residual fluorescence or relative fluorescence intensity (RFI=Fmax/F0×100) was 
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the fraction of the total protein fluorescence that was not quenched, and thus the 
fraction of β-Lg not bound to the ligand; where, F0 is fluorescence intensity of pure β-Lg; 
Fmax is the intensity at the emission maximum (λmax). A low ratio of RIF demonstrated a 
strong binding of the ligand, while a ratio of 100% indicated no binding. 
For the calculation of binding constant and binding number, the fluorescence quenching 
data were analysed by fitting to the Stern-Volmer equation (Liang et al., 2008) in dynamic 
quenching. Eq. (2): 
𝐅𝟎/𝐅𝐦𝐚𝐱 = 𝟏 + 𝐊𝐪 × 𝛕𝟎 × [𝐑𝐞𝐬𝐯𝐞𝐫𝐚𝐭𝐫𝐨𝐥] = 𝟏 + 𝐊 ×  [𝐫𝐞𝐬𝐯𝐞𝐫𝐚𝐭𝐫𝐨𝐥]               (2) 
F0 and Fmax are the fluorescence emission intensities without and with resveratrol; 
[resveratrol] is resveratrol concentration; Kq is the fluorescence quenching rate 
constant; τ0 is the fluorophore fluorescence lifetime without quencher, and K is Stern-
Volmer quenching constant. 
For the static quenching, the binding constant Ks and binding number n can be 
calculated according to the double logarithmic equation(He et al., 2016). Eq. (3): 
𝐥𝐨𝐠 [(𝐅𝟎 − 𝐅𝐦𝐚𝐱)/𝐅𝐦𝐚𝐱]) =  𝐥𝐨𝐠𝐊𝐬 + 𝐧 𝐥𝐨𝐠[𝐫𝐞𝐬𝐯𝐞𝐫𝐚𝐭𝐫𝐨𝐥]                 (3)                      
3.2.8. Statistical analysis 
Figures were plotted using MS Excel, MS Office 2013 (Microsoft Corporation, Redmond, 
WA, USA). The results were statistically analysed by analysis of variance using IBM® 
SPSS® Statistics version 20.0. Means and standard deviations from at least two 
measurements carried out on two samples repeated. The significance level was set at 
0.05. Data fitting of experimental data to models was performed with Excel MS Office 
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2013 (Microsoft Corporation, Redmond, WA, USA)  
3.3. Results and discussion  
3.3.1. The solubility of resveratrol in aqueous solution 
The solubility of resveratrol in water solution was determined by measuring total 
phenolic content using the direct spectrophotometric method and Folin-Ciocalteu 
method. 
In the direct spectrophotometric method, the Lambda max of 2mg/100ml resveratrol 
aqueous solution was determined as 303 nm. Therefore, a plot of the absorbance at this 
wavelength against concentration was established. The absorbance of resveratrol 
reached a peak and levelled off at resveratrol concentration 7mg/100ml after an 
approximately linear increase (Figure 3.2). Results from Folin-Ciocalteu method showed 
the same trend, and at 7mg/100ml the GAE also remained constant at about 35.5 mg/L. 
Both these results indicated that 7mg/100ml corresponded to the limit of solubility of 
resveratrol in water. Surprisingly, it was in disagreement with the reported solubility 
value (3mg/100ml), but this was determined by high-performance liquid 
chromatography (HPLC) (Jeon et al., 2016; Pujara et al., 2017; SantaCruzBiotechnology, 
2017). Moreover, the solubility value reported by Camont et al. (2009) using the UV 
spectrophotometric method was 6.85 mg/100ml, but they claimed that this increased 
solubility was due to sonication that helped to dissolve resveratrol. Another possible 
explanation of this different result was that, in our method, samples were not filtered 
prior to absorbance measurements, so any insoluble particles of resveratrol in 
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suspension could have led to an overestimation of the solubility. However, filtration was 
not still an option in this study due to the reasons below: filtration of aqueous solutions 
of resveratrol with a 0.45μm Polyethersulfone (PES) membrane proved to be very 
difficult as all resveratrol was retained (results obtained by HPLC but not shown here). 
Only the 0.22 μm Polypropylene (PVDF) filters showed high permeability for resveratrol 
but still, a reduction (7.69%) in absorbance observed. Moreover, high retention for β-Lg 
nanoparticles (about 80%) of 0.22 μm PVDF filter existed. Therefore, filtration was not 
applied in this work. Indeed, as mentioned before, the insoluble resveratrol particles 
might influence the total phenolic determination by direct absorbance measurement, 
however, particularly in the Folin assay, 0.5 ml samples were taken to carry out the assay 
and 20 times dilution was applied so any interferences by suspended particles would be 
minimal. 
 
Figure3.2: The solubility of resveratrol in aqueous solution. • Results of the direct 
spectrophotometric method ■ Results of Folin-Ciocalteu method. 
To sum up, in this study, the solubility of resveratrol in deionized water at room 
temperature was 7mg/100 ml. As our solubility result was higher than some of the 
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reported values, it was assumed that at 7ml/100 ml, a nearly saturated solution of 
resveratrol was obtained. Therefore, the rest of experiments were carried out at the 
range of 1mg/100ml to 7mg/100ml. 
3.3.2. The effect of light on resveratrol solubility and stability  
For the stability to light, the resveratrol suspensions were exposed to the lab light for 12 
hours. Based on the measurement of the direct spectrophotometric method, the 
concentration of resveratrol had an increasing trend with one exception at 1mg/100ml 
(Fig 3.3). Also, according to Figure 3.3, there was a reduction of GAE value at 1mg/100ml, 
but no significant difference at 3mg/100ml-7mg/100ml during 12 hours light exposure 
with a wide variance. Corresponding to the total phenolic content, inhibition% had the 
same increasing trend at 3mg/100ml-7mg/100ml. A significant positive correlation 
between total phenolic content (the direct spectrophotometric method) and total 
antioxidant capacity was observed as Pearson value was 0.844. Therefore, it was 
concluded that the resveratrol solution was not stable when exposed to lab light. 
Simimalrly, Pinelo, Rubilar, Sineiro, and Núñez (2005) found that resveratrol solution 
achieved maximum antioxidant activity at 22°C in water bath after three days.  
Also, according to Orgován, Gonda, and Noszál (2017), the trans-resveratrol is more 
lipophilic than its isomer. Moreover, they also found that the cis-resveratrol has over 
ten times more solubility than trans-resveratrol. Another potential explanation could be 
that at high concentration, the trans-resveratrol converted to cis-resveratrol under the 
light condition and more cis-resveratrol dissolved in the solution leading to an increase 
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in antioxidant activity. 
 
 
 
Figure 3.3: the stability of resveratrol to light by total phenolic content at 303nm (A), 
total phenolic content by Folin-Ciocalteu method (B) and total antioxidant capacity by 
ABTS (C). ■0h ■1h ■3h ■6h ■12h.  
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3.3.3. The characterization of resveratrol-ß-lactoglobulin nanoparticles 
After heating the mixture of resveratrol and ß-lactoglobulin (0.2%w/v) to form 
nanoparticles, the size of nanoparticles was measured by dynamic light scatting. The 
average size of resveratrol-ß-lactoglobulin nanoparticle was 181.80 nm±1.48 nm with 
polydispersion index 0.048 (in Figure 3.4). The nanoparticle size was close to Fonseca, 
Khalil, and Mainardes (2017) work (175nm), which encapsulation resveratrol with 
bovine serum albumin nanoparticles by desolvation method with ethanol. There was no 
significant difference in size among different concentrations of resveratrol nanoparticles 
and nanoparticles alone. It manifested that the nanoparticles around 200nm have been 
produced and the concentrations of resveratrol will not influence the size of 
nanoparticles. On the other hand, the size of nanoparticle was smaller than the 
nanoparticles we produced in previous work due to the lack of hydration step at 4 °C 
overnight. The reason why no hydration appiled was possibly unstable of resveratrol 
during storage .  
 
Figure 3.4: The example of the size distribution of resveratrol- ß-lactoglobulin 
nanoparticle by DLS. 
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3.3.4. Effect of heating, native ß-lactoglobulin, and resveratrol-ß-lactoglobulin 
nanoparticles on the stability of resveratrol  
The effect of heating was investigated under the same conditions as those used in the 
ß-lactoglobulin nanoparticles preparation: heating at 75°C for 45 mins. After heating, 10 
minutes in the ice bath allowed rapid reduction of samples temperature to room 
temperature. The concentration of native ß-lactoglobulin added to the resveratrol 
solution was the same as that used in the preparation of nanoparticles. The stability of 
resveratrol after the heating, protein addition and nanoparticles treatments was 
assessed by comparing the total phenolic content (Folin-Ciocalteu method), and total 
antioxidant activity (ABTS method and the Frap method) of treated samples with those 
of the control (resveratrol aqueous solution 1mg/100ml-7mg/100ml).   
3.3.4.1. Total phenolic content by Folin-Ciocalteu method 
According to Figure 3.5, results revealed a clear increment of GAE value after heating at 
all concentrations, indicating that the heating has a significant influence on resveratrol. 
Even though heating could improve the solubility of resveratrol in water dramatically 
(Filipa et al., 2003) as in this study all samples were subjected to an ice bath after heating, 
the increase of solubility due to heating would have been reduced or eliminated. So the 
increase in GAE observed at all concentrations, particularly those below the solubility (< 
7 mg/100 ml) could be due to chemical changes in the molecule which resulted in 
changes in its oxidative status and/or oxidation power and led to enhanced blue colour 
production. However, at 7 mg/ 100 ml, the big increase in GAE from 30.01 to 81.46 mg/L 
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may also be partly due to an increase in solubility since near saturation might have been 
reached at this concentration of resveratrol. Flieger et al. (2017) pointed out that when 
the temperature reached 75°C or above, heating could induce the isomerization of 
resveratrol from trans-resveratrol to cis-resveratrol even without light. Also, Orgován et 
al. (2017) found that the solubility of cis-resveratrol was over ten times more than that 
of trans-resveratrol in water as trans-resveratrol was more lipophilic than its isomer. 
Thus, a possible explanation for the increase in GAE observed here could be that some 
of the trans-resveratrol isomerized to cis-resveratrol and that led to an increase in 
solubility. 
When adding native ß-lactoglobulin, an increase in total phenolic content happened, 
while this increase was not significant (P>0.05) compared with to control sample at all 
concentrations. The interference of protein on total phenolic content has been 
eliminated by subtracting the GAE value corresponding to the protein from results (see 
Methods in 3.2.3). So any increases in GAE as a result of protein addition may be due to 
interactions between native ß-lactoglobulin and resveratrol that could lead to an 
increase in GAE, this is particularly the case for resveratrol concentration 3 and 5 
mg/100ml, which are below and about the solubility of resveratrol.  
Moreover, according to Figure 3.5, the samples of resveratrol with ß-lactoglobulin 
nanoparticles had the largest increment in phenolic content among these three 
treatments, and it was around three times the phenolic content of the control sample 
at all concentrations. Interestingly, the nanoparticles (combined the effect of heat and 
the addition of protein) led to a much higher increase than the heating alone for those 
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concentrations of RSV below solubility whereas for the highest concentration it had 
almost the same effect than heating alone. 
Overall these results suggested that heating enhanced resveratrol and ß-lactoglobulin 
interactions as well as inducing isomerisation thus, these combined effects led to an 
increase in total phenol content. For the highest resveratrol concentration which was 
about saturation point, this increase in total phenols can be also translated into an 
increase in solubility.  
 
 
Figure 3.5: The total phenolic content results by Folin-Ciocalteu method of resveratrol, 
heated resveratrol and resveratrol-native ß-lactoglobulin, and resveratrol-ß-
lactoglobulin nanoparticles. (Results were expressed at Gallic Acid Equivalents GAE 
mg/L) ■Standard RSV ■Heated RSV ■RSV+Native ß-Lg ■RSV+Nanoparticles of 
ß-Lg 
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3.3.4.2. Total antioxidant activity by ABTS method and Frap method 
Besides total phenolic content, the total antioxidant capacity was another important 
property of resveratrol. Changes in this as a result of the different treatments were used 
to assess the stability of resveratrol. In this work, two methods were applied to measure 
antioxidant capacity: ABTS method and Frap method. Results in Figure 3.6 
demonstrated a reduction of antioxidant activity measured as inhibition% after heating 
(P<0.05) at all concentrations. According to Mikulski, Gorniak, and Molski (2010), trans-
resveratrol was a stronger antioxidant than cis-isomer due to the planar conformation; 
this conformation would ensure the main parameters contributing to antioxidant 
activity: favourable spin and unpaired electron distribution. Therefore, reduced 
antioxidant activity confirmed that trans-resveratrol might change to cis-isomer during 
the heating as also suggested by total phenols results above (section 3.3.3.1).  
The addition of native ß-lactoglobulin led to no significant changes in antioxidant activity 
when compared against the control samples, indicating that the antioxidant activity 
would not be masked by ß-lactoglobulin. 
On the other hand, the resveratrol-ß-lactoglobulin nanoparticles had higher activity than 
heated samples (P<0.05) at 1-5 mg/100ml. So the reduction in activity due to heating 
was counteracted by the interactions of resveratrol with the nanoparticles which led to 
similar or higher activity than control. This suggests a protective effect of ß-lactoglobulin 
nanoparticles against heat-induced loss of antioxidant activity. Interestingly, at 
7ml/100ml, the difference in antioxidant activity between the heated sample (14.52%) 
and resveratrol-ß-lactoglobulin nanoparticle samples (21.31%) was not statistically 
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significant (0.072). At 7 mg/100 ml, the heating led to two counteracting effects, 
improving solubility which would increase activity and isomerization which would result 
in reduced activity, this is why both the heating effect and the nanoparticles did not have 
a significant impact on antioxidant activity. 
 
 
Figure 3.6: The total antioxidant activity results by ABTS method of resveratrol, heated 
resveratrol and resveratrol-native ß-lactoglobulin, and resveratrol- ß-lactoglobulin 
nanoparticles. Results were expressed as inhibition% (I%) ■Standard RSV ■Heated 
RSV ■RSV+Native ß-Lg ■RSV+Nanoparticles of ß-Lg. 
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mg/100ml. 
A reduction in activity due to heating was observed for samples up to 5mg/100ml in 
agreement with ABTS measurements (Fig 3.6). Surprisingly, and contrary to what was 
observed by the ABTS method, a sharp increase was observed at 7mg/100ml. This 
phenomenon could be explained by an increase in solubilized resveratrol in the form of 
cis-resveratrol as a result of heating. Therefore, both trans-resveratrol and cis-
resveratrol contributed to the antioxidant activity. These results also supported that the 
solubility of resveratrol in water might be below 7mg/100ml.  
 
Figure 3.7: The total antioxidant activity results by Frap method of resveratrol, heated 
resveratrol and resveratrol-native ß-lactoglobulin, and resveratrol-ß-lactoglobulin 
nanoparticles.Results were expressed as Ascorbic Acid Equivalents (AAE mg/ml) 
■Standard RSV■Heated RSV■RSV+Native ß-Lg■RSV+Nanoparticles of ß-Lg. 
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control samples (P>0.05). These results are in agreement with ABTS results. It was noted 
that the increase in AAE value of resveratrol-ß-lactoglobulin nanoparticles compared 
with the AAE value resveratrol-native ß-lactoglobulin was a significant difference, which 
was not observed by ABTS method. This was probably related to the different 
mechanisms of these two antioxidant activity measuring assays. In principle, blue/green 
ABTS•+ chromophore produced by the reaction between ABTS and potassium persulfate 
was measured spectrophotometrically at 734 nm, and this radical cation converted back 
to its colourless neutral form after reacting with antioxidants (Gülçin, 2010; Re et al., 
1999). In this study, one of the main limitations of ABTS method was that the radicals 
were generated at least 16 hours before the reaction of ABTS with potassium 
persulphate, but assays were carried out with radicals generated at different times (not 
exactly 16 hours). Thus, it led to ABTS•+ radicals with different activities and influenced 
stability and reproducibility of results. On the other hand, the principle of Frap method 
was based on the reduction of Fe3+ to Fe2+ ions which results in the formation of an 
intense blue colour. According to Gülçin (2010), both Frap and ABTS methods worked 
effectively to determine the antioxidant activity of resveratrol, but different results were 
obtained for the same antioxidant samples.  
Nevertheless, the results of both antioxidant capacity methods indicated that ß-
lactoglobulin nanoparticles had the ability to prevent the deterioration of resveratrol 
during heating and protected its antioxidant capacity. In addition, ß-lactoglobulin had a 
more effective protective effect in the nanoparticle than native form. 
Therefore, in order to obtain an improved understanding of the interactions between ß-
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lactoglobulin and resveratrol and binding mechanism, the fluorescence measurements 
were conducted. 
3.3.5. Determination of ß-lactoglobulin-resveratrol interactions by fluorescence 
The fluorescence measurements of resveratrol-β-lactoglobulin solutions were 
conducted with resveratrol concentrations from 0.23mg/100ml-2.5mg/100ml. 
During heating, the tertiary structure of native β-lactoglobulin was broken, the protein 
conformation opened up and the more hydrophobic residues became more exposed 
which should promote hydrophobic interactions and hydrogen bonding between β-
lactoglobulin and ligands. The shifted λmax to a longer wavelength indicated that the 
heating exposed the previously buried Trp and Tyr residues (shifting of λmax from 
wavelength 337.0 nm to 357.14 nm and 335.08nm to 377.89nm in Figure 3.8) and the 
shifting of nanoparticles was larger than that of native β-lactoglobulin, which indicated 
more exposure of the fluorophore groups due to changes in β-lactoglobulin 
conformation as a result of heating during nanoparticles production. In Table 3.1, the 
RFI value decreased as the concentrations of resveratrol increased with both native and 
nanoparticles. The RFI value of resveratrol-native β-lactoglobulin (22.87) was smaller 
than the value of resveratrol-β-lactoglobulin nanoparticles (46.67), which indicated 
stronger binding of Resveratrol with native β-lactoglobulin than with its nanoparticles. 
This result was in disagreement with our previous work with caffeine where 
nanoparticles showed higher binding affinity than native β-lactoglobulin (Guo et al., 
2017). 
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Table 3.1: the fluorescence measurement of Resveratrol standard, Resveratrol with 
native β-Lg, Resveratrol-β-Lg nanoparticles at different concentrations. 
Concentration 
(mg/100ml) 
 
   
Resveratrol with native β-Lg Resveratrol-β-Lg nanoparticles 
Fluorescence 
Intensity (a.u.) 
RFI (%) Fluorescence 
Intensity (a.u.) 
RFI (%) 
0 370.30±0.46 100.00 196.57±0.20 100.00 
0.23mg/100ml 328.77±0.09 88.78 164.53±0.48 83.70 
0.46mg/100ml 258.36±0.54 69.77 163.41±0.08 83.64 
0.92mg/100ml 172.25±0.04 46.52 162.54±0.25 82.69 
1.84mg/100ml 119.73±0.57 32.33 128.76±0.02 65.50 
2.48mg/100ml 84.69±0.28 22.87 91.72±0.12 46.67 
 
Figure 3.8: The fluorescence emission spectra of (A) resveratrol-native β-lg at 
0mg/100ml-2.48mg/100ml (1-6); (B) resveratrol-β-lg nanoparticle at 0mg/100ml-
2.48mg/100ml (1-6). 
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Furthermore, According to Eq (1), the Stern-Volmer equation constant, K of Resveratrol 
with native β-Lg was 3.18х104 M-1 (R2= 0.986) and since τ0 is 1.28 ns for Trp of β-Lg 
(EricDufour, Genot, & Haertlé, 1994; Stojadinovic et al., 2013), Kq was 2.5х1013 M-1S-1, 
which was higher than the maximal dynamic quenching constant (1-2.0 × 1010 M-1S-1) 
and it suggested binding of resveratrol with β-Lg followed a static quenching mechanism. 
In this case, the fluorophore formed a stable complex with another molecule, and it was 
non-fluorescent. This result was in agreement with Liang and Subirade (2012); Liang et 
al. (2008), who confirmed that β-Lg fluorescence quenching induced by resveratrol is a 
static quenching. Thus, based on Eq. (2), the binding constant Ks was 1.67х105 M-1and 
the binding number was 1.33. This means 1.33 resveratrol molecules bind one β-Lg 
molecule and also Ks was in the range of 105 and 106 M-1, which was in agreement with 
binding constants reported for native β-Lg and a range of substrates by Liang and 
Subirade (2010) (binding with folic acid: 4.3× 105M-1), Shpigelman, Israeli, and Livney 
(2010a) (binding with EGCG: 1.05× 105M-1), Liang et al. (2008) (binding with 
Resveratrol:104 ~105M-1 ). 
However, when applying the Stern-Volmer quenching equation to Resveratrol with β-Lg 
nanoparticles samples, K of Resveratrol with β-Lg nanoparticles was 9.1х103, but the R2 
was 0.852. This indicated that the resveratrol to β-Lg nanoparticles binding did not follow 
the Stern-Volmer model. Moreover, the resveratrol-β-Lg nanoparticles did not fit the 
Langmuir-type model, either (data did not include here, but R2 was 0.55).  
To sum up, according to the fluorescence results, native β-Lg had higher binding affinity 
for resveratrol than its nanoparticles; the binding constant for native protein was 
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1.67х105, and the binding number was 1.33. However, no model was found to fit the 
binding of β-Lg nanoparticles with resveratrol. This is contrary to what was observed for 
caffeine and β-Lg in our previous work (chapter 2). According to Shpigelman et al. (2010) 
claimed a higher association of heated β-Lg with Epigallocatechin-3-gallate (EGCG) than 
native β-Lg, but Perez, Andermatten, Rubiolo, and Santiago (2014) demonstrated no 
significant difference in binding linoleic acid between native and heat-induced β-Lg 
aggregates. Therefore, the mechanism of interactions between different ligands and β-
Lg should be different. The influence on binding properties of heat-induced β-Lg 
nanoparticles has different results depends on the ligand.  
3.3.6. The effect on stability of resveratrol among different treatments under 
pasteurisation  
Pasteurisation is a common commercial method to minimise health hazards from food 
pathogen and to extend shelf life for liquid food and drinks. Thus, it is important to 
examine the effect of pasteurisation on resveratrol stability and how would adding 
protein affect this. So here the aim is to apply the knowledge obtained in the 
experiments described above to an industrial thermal process. Firstly, as shown in figure 
3.9 A, total phenolic content of resveratrol after pasteurisation showed the same results 
as the heating at 75 °C: dramatic increase of GAE value after pasteurisation. Secondly, it 
demonstrated that pasteurising resveratrol with native β-lactoglobulin had no 
significant difference in total phenolic content at all concentrations as compared to 
control. It was different with results when producing nanoparticles at 75°C, which 
showed a significant addition of total phenolic content. At this temperature, β-
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lactoglobulin existed as a monomer in solution, and the tertiary structure started slightly 
changing (Blanpain-Avet et al., 2016). A possible reason could be that the interaction 
with β-lactoglobulin suppressed the chemical changes in resveratrol molecule at 63°C. 
Surprisingly, after pasteurisation of resveratrol-β-lactoglobulin nanoparticles, a 
reduction of total phenolic content happened at all concentrations.  
On the other hand, the antioxidant activity (%inhibition) of standard resveratrol slightly 
reduced after pasteurisation at 1mg/100ml and 3mg/100ml but increased at 5mg/100ml 
and 7mg/100ml (Figure3.9 B). These results were different to results of heating at 75°C, 
which indicated that heating at 75 °C led to more degradation than at 63°C, and here 
samples were not put in an ice bath after Pasteurisation so solubility might increase by 
heating.  
Our results were in agreement with those by Pinelo et al. (2005)’s work, who reported 
that an increase of the total antioxidant capacity of resveratrol solution (100mM) 
happened during heating at 60°C and the maximum value achieved at 6 hours. They 
explained that the initial increment on total antioxidant activity occurred in two steps of 
resveratrol oxidation. In the first period of storage, the weight of the polymerization 
pathway might be lower than that of the formation of the o-diphenol core, which gave 
more antioxidant activity. Also, the results of both native β-lactoglobulin and 
nanoparticles after pasteurisation resulted in an increment of total antioxidant activity. 
This suggested that during heating β-lactoglobulin denatured and this promoted 
interactions between the protein and resveratrol. Pasteurisation would enhance this 
interaction and lead to an increased antioxidant activity. It was noted that the activity 
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of resveratrol-native-β-lactoglobulin after pasteurisation was higher than the activity of 
resveratrol-β-lactoglobulin nanoparticle samples before pasteurisation. This may be due 
to the effect of heating on solubility. In addition, it also suggested that the heat-induced 
isomerisation was stronger at 75°C than at 63°C. 
 
 
Figure 3.9: The total phenolic content (A) and the total antioxidant activity (B) of 
resveratrol, resveratrol with native β-Lg, Resveratrol-β-Lg nanoparticles before and 
after pasteurisation.■RSV before pasteurisation■RSV after pasteurization  
■RSV+native β-Lg before pasteurisation■RSV+native β-Lg after pasteurization 
■RSV+ β-Lg nanoparticles before pasteurisation■RSV+ β-Lg nanoparticles after 
pasteurisation. 
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3.4. Conclusions  
In this work, the solubility of resveratrol in water was determined as 7mg/100ml by 
directly spectrophotometric and Folin-Ciocalteu method. However, it seemed that the 
solubility should be below this value based on the results of heated samples. Resveratrol 
was not stable to light, and light exposure resulted in higher phenolic content and total 
antioxidant capacity. Nanoparticles of β-lactoglobulin in the present of resveratrol were 
produced in size around 181.8nm, and the concentration of resveratrol was proved to 
have no significant difference in the size of nanoparticles. The thermal degradation and 
isomerization of resveratrol at 75°C led to reduced antioxidant capacity. Both native β-
lactoglobulin and its nanoparticle form showed a protective effect on the antioxidant 
capacity of resveratrol against heat degradation. Moreover, the addition of β-
lactoglobulin nanoparticles led to an increase in antioxidant activity. Surprisingly, 
according to fluorescence measurement, the results of RFI demonstrated that native β-
lactoglobulin had stronger binding than its nanoparticles. Moreover, the binding 
constant of native β-lactoglobulin with Resveratrol is 1.67х105, and the binding number 
is 1.33 following Stern-Volmer model, but no model was found to fit the binding of 
resveratrol to nanoparticles. In summary, stronger interactions between native β-
lactoglobulin and resveratrol than with its nanoparticles, despite the latter showing 
more protective effect. Therefore, β-lactoglobulin is a good candidate to improve the 
stability and antioxidative properties of resveratrol and could be used as an encapsulant 
to protect resveratrol during thermal processing. Our work gives solid evidence to prove 
that β-lactoglobulin nanoparticles could protect and enhance antioxidant activity of 
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resveratrol under pasteurisation conditions. Further studies should follow to investigate 
the stability of resveratrol during other industrial thermal processes like spray drying 
and ultra-heat treatment.  
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CHAPTER FOUR                                                    
Further study of β-lactoglobulin nanoparticles and production of whey protein 
nanoparticles  
ABSTRACT 
In this chapter, the stability of β-lactoglobulin nanoparticles produced by the heat-
induced method has been examined under different processing and treatment 
conditions. Ethanol is a common solvent for hydrophobic compounds and it is widely 
used in food products. Adding ethanol reduced the charge of solution leading to a 
smaller zeta potential, therefore, larger aggregates were produced at increased ethanol 
content. Sedimentation of nanoparticles happened when centrifugation was applied at 
high speed (>863g)  thus, less protein concentration remained in the supernatant. 
Freeze-drying had no significant influence on particle size when compared freshly made 
samples with redispersion freeze-dried samples; however, the latter had higher PDI 
indicating reduced sized distribution uniformity. On the other hand, whey protein 
nanoparticles were produced with the same method. The size of whey protein 
nanoparticle was in a range of 150 to 350nm and the size depended on the concentration 
of protein. However, the aggregation yield of whey protein nanoparticles was lower than 
with β-Lg (maximum obtained was 85% whilst it was 93% with -Lg). Nevertheless, these 
results showed that whey protein nanoparticles can be prepared with this method. It is 
practical to use whey, a cheaper and abundant source to prepare nanoparticle in the 
food industry. Further studies are necessary to investigate proteins interactions in the 
nanostructure of whey protein nanoparticles.  
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4.1. Introduction 
In the last two chapters, β-lactoglobulin nanoparticles in a range of 200nm-300nm have 
been produced by simple and robust heat-induced method, and intermolecular non-
covalent interactions (hydrogen bonding and hydrophobic interactions) were proved to 
be the predominant interactions responsible for the microstructure of the nanoparticles. 
Applications including encapsulation of caffeine and resveratrol have been successfully 
developed. Numerous bioactives have low water solubility, thus, when encapsulating 
these nutraceuticals, organic solvents are applied in order to dissolve these compounds. 
Ethanol is the most common, and it is classified as generally recognised as safe (GRAS) 
solvent, but up to a concentration limit. The concentration of ethanol in food reported 
as GRAS was around 3% (FDA, 2017a, 2017b, 2017c) and it depends on the type of food. 
Ethanol has an influence on the charge of protein, organisation of dipolar moments, the 
secondary structure of the protein, and even the binding properties (Mousavi, Chobert, 
Bordbar, & Haertle, 2008). Also, Gulseren et al. (2012) developed a method to produce 
whey protein isolate (WPI) and β-lactoglobulin nanoparticles around 100nm with 
desolvation method using ethanol. On the other hand, in Chapter three, when 
entrapping resveratrol, there was a proposal that ethanol was used to dissolving the 
resveratrol (details were discussed in Chapter Five). Therefore, it is interesting to study 
the effect of ethanol on the β-lactoglobulin nanoparticle. Meanwhile, centrifugation is a 
common step in food processing for solids separation from the liquid. Some of the 
studies use high-speed centrifugation to separate encapsulated bioactives from free 
bioactives to determine the encapsulation efficiency of nanoparticles product 
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(Gülserena et al., 2012; Pujara et al., 2017; Patricia Zimet & Yoav D. Livney, 2009). In 
detail, the free bioactives floated in the supernatant after centrifugation, and the 
particles (pellet) sedimented at the bottom with entrapped bioactives. Thus it is 
interesting to investigate the influence of centrifugation on the nanoparticles. Also, 
freeze drying is a common approach to extend the shelf life of the product by reducing 
the moisture content, and it is especially applied to heat sensitive bioactives.  
Moreover, whey protein is more economical than pure β-lactoglobulin to produce 
nanoparticles and more convenient to use particularly for industrial applications. , As β-
lactoglobulin is the main protein in whey (about 50% of total protein in whey). Here the 
method applied for β-lactoglobulin is applied to produce whey protein nanoparticles.  
The aim of this chapter is, as an extension of the studies presented in chapters two and 
three, to explore the effects of ethanol, centrifugation and freeze drying on the stability 
of β-lactoglobulin nanoparticles and to examine the feasibility of applying the method 
developed for β-lactoglobulin to produce whey protein nanoparticles. 
 
4.2. Materials and methods  
4.2.1. Materials 
β-Lactoglobulin from bovine milk ≥85% (PAGE), lyophilized powder L2506 is purchased 
from Sigma 
Ethanol absolute, ≥99.8% (GC) (32221-M) is purchased from Sigma 
Bicinchoninic Acid solution (B9643-1L) and Copper sulphate solution (C2284) are 
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purchased from Sigma 
4.2.2. The effect of ethanol on nanoparticles  
The β-Lg nanoparticles were prepared following the method 2.2.1 at pH 6.0 with 
different concentration of ethanol ranged from 0%, 7%, 14%, and 28%. The particle size 
was measured by Dynamic light scattering (Malvern Instruments Inc., Malvern, United 
Kingdom) at room temperature. The measurement was determined by considering the 
refractive index of β-Lg as 1.45, and that of the dispersant medium (deionised water) as 
1.33 and the refractive index of ethanol was 1.34-1.35 based on the value from Belda, 
Herraez, and Diez (2005), Refractometer.pl (2017). Zeta potential was measured by 
measured by Zetasizer Nano Z in Electrophoretic Light Scattering mode (Malvern 
Instruments Inc., Malvern, United Kingdom). A folded capillary cell (DTS1070) was used 
to measure the zeta potential. The cell was washed with Ethanol and Deionised water 
before each measurement. 
4.2.3. The effect of centrifugation on nanoparticles. 
The β-Lg nanoparticles were prepared following the method 2.2.1 at pH 6.0. The samples 
were centrifuged at 863g (2000rpm), 5400g (5000rpm) with Heraus Multifuge 3SR+ 
centrifugation machine (Thermo Scientific, Waltham, USA) and 9788g (9600rpm) with 
MiniSpin (Eppendorf). After centrifugation, the supernatant was taken to carry out the 
Bicinchoninic acid assay to measure the total protein concentration, and the size of the 
supernatant was measured by DLS. Briefly, 0.1 ml of the sample was added to 2 ml of 
BCA working reagent (bicinchoninic acid and copper (II) sulphate pentahydrate), 
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followed by incubation at 37°C for 30 min. The reaction solution was measured at 562 
nm in an Ultrospec ® 1100 PRO UV-vis spectrophotometer (United Kingdom), and a 
calibration curve was established using β-Lg nanoparticles ranged from 0-1000 μg/ml. A 
β-Lg nanoparticles sample without centrifugation was used as the control group.  
4.2.4. The effect of freeze drying on particle size 
The β-Lg nanoparticles were prepared by the method mentioned at 2.2.1 at pH 6.0. Then, 
3ml of the sample was transferred to 7 ml Sterile container and covered with lab tissue 
paper, which was fastened by tape. Then, the container was put into Freeze Dryer (VirTis 
SP Scientific Sentry 2.0) and samples were freeze drying for three days. Then, the 
samples were resuspended in the same volume of deionized water and the particle size 
of both nanoparticles and redissolving samples were measured by DLS 
4.2.5. Whey protein nanoparticle preparation 
4.2.5.1. Preparation of sweet whey  
Sweet whey was prepared by the modified method described in Welderufael, Gibson, 
and Jauregi (2012). Pasteurised skimmed milk was purchased from the local Tesco shop 
and heated in a water bath (Grant Instrument Ltd., Cambridge, United Kingdom) at 37OC. 
Then commercial rennet was added at the concentration of 0.3mL/L into 500ml of milk 
sample with 2mins stirring. The milk was incubated for 60mins, and then the casein 
coagulum was cut vertically (25 X 25 mm) by a knife and then, incubation was allowed 
to prolong for 20 min after which the whey was collected from the vessel and filtered 
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using cheese cloth. Then whey solution was transferred into 50ml Falcon tube and 
carried out centrifugation at 2212g (3200rpm) for 30 min, using a Heraus Multifuge 3SR+ 
centrifuge (Thermo Scientific, Waltham, USA). Additionally, the sweet whey was filtered 
using microfiltration syringe membrane of 0.45μm pore size to remove any remaining 
casein curds. The collected whey was stored at -20oC until used for further experiments. 
4.2.5.2. Protein concentration determination of sweet whey 
Protein concentration in sweet whey was determined by bicinchoninic acid method (BCA) 
based on the method 2.2.4. For protein samples with unknown concentration, the 
selected dilutions (10-fold, 20-fold, and 50-fold dilution) of sweet whey were prepared 
to ensure the concentration was within the linear range of 200-1000µg/ml. Experiments 
were performed in triplicates.        
4.2.5.3 Sweet whey nanoparticle and its particle size measurement 
After determination of protein content in sweet whey, solutions with different protein 
concentrations (% w/v) were prepared; 0.2, 0.3, 0.5, and 1.0 % w/v. 200ppm Sodium 
azide (200ppm) was added to stock whey solutions to prevent microbial growth, and the 
solutions were stored at fridge (4oC). Then, the method described in 2.2.1 for production 
of β-Lg nanoparticles was applied to produce the whey protein nanoparticles, and the 
particle size was measured by the DLS method (refer to the section). All experiments 
were carried out in triplicate. The yield of whey protein aggregation was determined by 
separating the denatured whey nanoparticles from native whey using centrifugal 
ultrafiltration Vivaspin® 20 (Sartorius Stedim Biotech, Germany) with 50kDa weight cut-
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off PES (Polyethersulfone) membrane. To quantify the amount of native and aggregated 
whey protein, 5ml of the whey nanoparticles solution was centrifuged at 863g (Heraus 
Multifuge 3SR+ centrifuge, Thermo Scientific, Waltham, USA) for 15 minutes to separate 
the nanoparticles and native proteins. The retentate and permeate volumes were 
determined by weight, and the protein concentration in permeate was determined by 
BCA method in 2.2.4. The percentage of protein aggregated was determined by 
measuring the total protein in permeate and by applying a mass balance of protein as 
shown in Eq. (1):   
𝒀𝒊𝒆𝒍𝒅 𝒐𝒇 𝒘𝒉𝒆𝒚 𝒏𝒂𝒏𝒐𝒑𝒂𝒓𝒕𝒊𝒄𝒍𝒆% =
𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐦𝐚𝐬𝐬 𝐢𝐧 𝐟𝐞𝐞𝐝−𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐦𝐚𝐬𝐬 𝐢𝐧 𝐩𝐞𝐫𝐦𝐞𝐚𝐭𝐞
𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐦𝐚𝐬𝐬 𝐢𝐧 𝐟𝐞𝐞𝐝
               (1) 
 
4.3. Results and discussion 
4.3.1. The effect of ethanol on nanoparticles  
Compared with water, ethanol was far less polar, and when adding ethanol, the 
hydrogen-bonded water molecule will be replaced by the hydrogen-bonded ethanol in 
the protein-solvent interaction. Moreover, the tertiary and secondary structure of the 
protein has changed reversibly (Dufour, Bertrand-Harb, & Haertle ,´ 1993; Mousavi et al., 
2008). As shown in Figure 4.1, a clear increase in particle size with ethanol concentration 
was observed; on the contrary, the polydispersion index (PDI) reduced (0.1-0.063). On 
the other hand, the zeta potential of nanoparticles decreased dramatically with the 
addition of ethanol, as expected, which indicated that ethanol reduced the charge of 
protein and electrostatic repulsion among β-Lg and this possibly promoted further 
aggregation of protein into larger particles. According to Bhattacharjee (2016), 
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guidelines classifying nanoparticle-dispersions with zeta-potential values of ± 0–10 mV, 
± 10–20 mV, ± 20–30 mV and ˃ ± 30 mV as highly unstable, relatively stable, moderately 
stable and highly stable, respectively. Therefore, adding ethanol resulted in changes in 
stability of nanoparticles from highly stable with zeta potential -41.3mV to relatively 
stable with zeta potential -18.8 mV. According to Gulseren et al. (2012) and Gülserena et 
al. (2012), they produced whey protein nanoparticles around 100nm by ethanol 
desolvation method with a further dilution to achieve low ethanol concentration 
(around 1%). However, they still found that these nanoparticles at neutral or alkaline pH 
had low stability, and acidification to pH 3 was necessary to maintain the size of particles. 
It might indicate that ethanol desolvation was not able to stabilise of the dispersion.  
In summary, adding ethanol resulted in a reduction of zeta potential, thus, the charge of 
particles and led to the occurrence of large particles. 
 
Figure 4.1: The particle size and zeta potential of ß-Lg nanoparticles with different 
concentration of ethanol (0-28%).(Dark blue represents the particle size and light 
blue represents zeta potential) 
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4.3.2. The effect of centrifugation on nanoparticles 
The influence of centrifugation on nanoparticles was assessed by the protein 
concentration of the supernatant and particle size supernatant. According to Table 4.1, 
there was a slight reduction in protein concentration in the supernatant of samples 
centrifuged at 863g and none-centrifuged, while little protein remained in the 
supernatant after centrifuging at 9788g, which revealed that sedimentation of the 
nanoparticles happened due to the centrifugal force that disrupted the colloidal stability. 
Figure 4.2 demonstrated the effect of centrifugation on the particle size. There was no 
significant difference in particle size of nanoparticles in supernatant before and after 
centrifugation at 863g. At 5400g and 9788g, the particle size reduced dramatically (190.6 
nm and 131.7 nm, respectively) which was in agreement with the decrease in protein in 
the supernatant of these samples. Based on these results centrifugal speed 863g was 
chosen as on optimum centrifugal force in terms of colloidal stability of the nanoparticles. 
This was an important finding as if high speed of centrifugation was applied, the colloidal 
stability of particles would be disrupted and would also lead to a reduction in 
encapsulation efficiency.  
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Table 4.1: The results of protein concentration in the centrifugated supernatant by BCA 
method. 
 
UV [562nm] % of absorbance of 
none-centrifugation samples 
None-centrifugation nanoparticles 0.825±0.018a 100.00 
863g (2000 rpm) 0.763±0.008b 92.54±0.96 
5400g (5000 rpm) 0.327±0.006c 39.60±0.08 
9788g (9600 rpm) 0.028±0.001d 3.40±0.10 
Data were expressed as mean ± standard deviation for triplicate tests. Different superscripts in the 
same column indicate significant differences at P<0.05 
 
 
Figure 4.2: The particle size of samples after different speed centrifugation. 
4.3.3. The effect of freeze drying on the nanoparticles 
As the moisture content was eliminated during freezing drying, the ice formation led to 
oppression of particles away from frozen areas, thus, increasing the particle 
concentration and inducing a large particles agglomeration (Deville, Saiz, Nalla, & Tomsia, 
2006). Interestingly, when the effect of freeze drying on the particle size was assessed 
by comparing the particle size of freeze dried nanoparticles that had been resuspended 
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and freshly made nanoparticles no significant differences were observed, only a slight 
increase of the PDI. (Fig 4.3). Vries, Gomez, Jansen, Linden, and Scholten (2017) 
produced whey protein nanoparticles of around 150 nm by heating at 85 °C for 15 min 
at pH 5.7. A homogenization step was induced to break the weak gel into small 
aggregates in their work. They also found that freeze drying did not affect the particle 
size and therefore it was applied in order to eliminate moisture from the nanoparticles. 
 
Figure 4.3: The particle size of nanoparticles and redispersed freeze drying samples. 
(Dark blue represents the particle size and light blue represents PDI) 
4.3.4. Whey protein nanoparticles 
Compared with β-Lg, it is more economical and practical to use whey proteins to produce 
nanoparticles. In this work, sweet whey was used to generate nanoparticles. The protein 
concentration in sweet whey was determined as 11.0mg/ml (1.1% w/v), which 
corresponds to the value given by Boland (2011). The size of whey nanoparticles 
increased with the concentration of protein in samples. Interestingly, the particles size 
of the 0.2% w/v whey was around 150 nm, which was smaller than the β-Lg 
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nanoparticles at the same protein concentration. The size of 0.5% w/v whey samples 
was close to the size obtained with 0.2% w/v β-Lg. β-Lg is around 50% of total protein in 
whey. Thus, these results might indicate that β-Lg concentration in whey protein might 
have the main influence on the particle size and characteristics. Surprisingly, the PDI of 
1%w/v whey protein nanoparticles increased to 0.69, and a bimodal size distribution 
occurred, indicating nonuniformity of particle size and existence of larger aggregates 
exceeding the nanometer scale. Moreover, the unheated whey protein showed particle 
size above 100nm, which was not observed with native β-Lg (below 10 nm as a dimer). 
In sweet whey, some large proteins like Immunoglobulin G (150kDa) existed, and 
possibly oligomers of large proteins may be formed during the sweet whey processing 
(heating at 37°C). Sats et al. (2014) also found the particles over 100nm with high PDI in 
bovine colostrum whey, which contained more Immunoglobulin G. This might reflect 
that an ultrafiltration with proper molecule weight cut off membrane was necessary to 
eliminate the large whey proteins before the nanoparticle preparation.   
Table 4.2: Effect of protein concentration on the size of whey nanoparticles (Heat load, 
75oC 45mins; pH, 6) 
Protein concentration 
(%w/v) 
Particle size (nm) Polydispersity Yield of whey protein 
nanoparticle (%) 
0.2 150.85 ± 1.21d 0.18±0.02b 72.75±1.38% a 
0.3 170.20 ± 3.69c 0.15±0.01b 74.33±2.96% a 
0.5 231.07 ± 11.68b 0.18±0.02b 80.52±1.74% b 
1 351.90 ± 14.34a 0.69±0.17a 84.66±2.17% c 
Data were expressed as mean ± standard deviation for triplicate tests. Different superscripts in the 
same column indicate significant differences at P<0.05 
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Moreover, the yield of whey protein nanoparticle was calculated according to equation 
(1) (Table .4.2). It increased corresponding to protein concentration, but even the highest 
yield (85%) obtained at the highest concentration (1 mg/ml), it was still lower than the 
yield obtained with β-lactoglobulin nanoparticles (93%). This suggested that some of the 
whey protein did not contribute to the nanoparticle formation. Moreover, according to 
Ramos et al. (2017), there are complex protein-protein interactions, for example, the 
interaction between β-Lg and α-La. Therefore, the predominant interactions/forces to 
establish the three-dimensional network of the whey nanoparticles should be 
investigated. 
4.4. Conclusions 
In this chapter, the stability of β-Lg nanoparticles was investigated under several 
processing conditions. Adding ethanol reduced the zeta-potential of nanoparticles and 
led to large aggregates. Centrifugation at high speed resulted in sedimentation of 
nanoparticles and reduction of protein concentration in supernatant. Surprisingly, 
redispersion of freeze-dried samples had no significant effect on particle size. Lastly, 
whey protein nanoparticles were successfully produced with size in the range of 150 to 
350nm by applying the same method as that developed for β-Lg nanoparticles. However, 
the aggregation yield was lower for whey (maximum obtained was 85%) than with β-Lg 
(93%). Nevertheless, these results were promising and showed that particles of similar 
size can be obtained starting from whey, which is cheaper and more practical to use for 
industrial applications. Further studies need to be carried out to explore proteins 
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involved in the nanostructure of whey protein nanoparticles and characterization of 
these nanoparticles should be considered in terms of stability, storage and other food 
processing conditions. 
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CHAPTER FIVE 
Conclusions and future works 
5.1. Conclusions 
The emerging trend of novel delivery systems of bioactive compounds has already 
attracted extensive attention from the scientific community. In the present work, the 
aim was to explore if it was feasible to produce nanostructures from β-Lg in a consistent 
and reproducible manner by a simple heat-induced denaturation method. In particular, 
it was interesting to investigate if β-Lg nanoparticles play an effective role in bioactives 
encapsulation. On the other hand, it was worth studying if similar type of nanoparticles 
could be produced by the same method using whey. 
In the first part of the study, the main achievement was that β-Lg nanoparticles were 
produced by the heat-induced denaturation method at optimum conditions of pH (6.0) 
and heat load (heating at 75 °C for 45 mins), which were found to be key operating 
parameters (Chapter 2). Nanoparticles were around 200-300 nm with a monodisperse 
size distribution and with colloidal stability (this was due to their high negative charge as 
measured by zeta potential -37.42mV). High yield (93%) of aggregation of β-Lg was 
achieved. An improved insight of their formation was obtained where the main forces 
responsible for the protein aggregation and stabilisation of the nanoparticles were 
hydrogen bonding and hydrophobic interactions based on their lack of stability to urea 
and SDS, respectively. The exposure of buried hydrophobic parts of the protein upon 
unfolding of β-Lg due to heat denaturation was confirmed by the fluorescence 
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measurements. Consequently, all these results show that a robust and reproducible 
method was successfully developed to produce β-Lg nanoparticles by a simple heat-
induced denaturation method. Compared with the desolvation method which uses 
organic solvents, our method only needed pH adjustment and heat denaturation, which 
met the GRAS requirements. This facile method provides an innovative approach that 
can be applied to food products and has potential to be developed at industrial scale.  
In order to study the applicability of these nanoparticles to food bioactives, the 
encapsulation of the amphiphilic alkaloid caffeine was investigated (chapter 2). Caffeine-
loaded β-Lg nanoparticles (~350 nm) were significantly larger than the nanoparticles 
only, and maximum encapsulation efficiency was 13.54% at 50:1 caffeine to β-Lg molar 
ratio. The binding of caffeine to protein (both of native β-Lg and heat denatured β-Lg) 
followed a Langmuir type isotherm. Heating of β-Lg unfolded the previously buried and 
more hydrophobic parts of the protein which led to more binding of caffeine. β-Lg 
nanoparticles exhibited a rapid peptic degradation at SGF conditions as shown by a 
dramatic particle size reduction, however, limited release of caffeine (36.4%) was 
observed, which suggested that binding of caffeine was not dependent on the 
microstructure but relied mainly on interactions with the unfolded protein. The full 
release of caffeine happened after the small intestinal digestion phase. These findings 
suggested the potential capacity of β-Lg nanoparticles for the encapsulation of 
bioactives and their enteric release.  
Moreover, another application of the β-Lg nanoparticles focused on Resveratrol (Chapter 
3) because of its remarkable health-benefit properties including antioxidant, anti-cancer, 
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anti-inflammatory, and antineoplastic (Bhat & Pezzuto, 2002; Catalgol et al., 2012; Filipa 
et al., 2003). At the same time, there was a potential cooperation opportunity and 
funding from Evolva; they needed to explore a solution to increase the resveratrol 
solubility in water from 3mg/100ml to 3mg/ml. It seemed to be difficult to achieve this 
target without adding some organic solvent. However, the influence on the structure and 
binding properties of β-Lg were unclear and different depending on the types of solvents. 
Therefore, β-Lg nanoparticles were applied to encapsulate the resveratrol without 
adding organic solvent first. The solubility of resveratrol was firstly determined by total 
phenolic content at between 5mg/100ml-7mg/10ml and resveratrol was not stable to 
light but exhibited a higher phenolic content and total antioxidant capacity after 12 
hours light exposure at room temperature. There was an obvious thermal degradation 
happening when heating at 75°C since the loss of antioxidant capacity occurred as 
determined by both ABTS and Frap methods. Isomerization of trans-resveratrol to cis-
resveratrol might happen under these conditions. A protective function of β-Lg on the 
antioxidative properties of resveratrol was observed during heat degradation, and 
resveratrol-β-Lg nanocomplexes exhibited a higher total antioxidant activity than the 
control (resveratrol only), even though the binding of resveratrol by β-Lg nanoparticles 
was lower than native β-Lg. M. Li, Ma, and Ngadi (2013) also reported an improved 
antioxidant activity upon binding of curcumin to β-Lg. However, the fluorescence 
measurements demonstrated a clear interaction between these two molecules, but 
surprisingly, the RFI indicated that the binding between native β-Lg and resveratrol 
(22.87%) was stronger than resveratrol-β-Lg nanocomplexes (46.67%). This was 
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opposite to what was observed for caffeine binding. Moreover, interestingly, 
Shpigelman et al. (2010b) claimed a higher association of pre-heated β-Lg with 
Epigallocatechin-3-gallate (EGCG) than native, while Perez et al. (2014) reported no 
significant differences in binding linoleic acid between native and heat-induced β-Lg 
aggregates. Also, Shpigelman, Shoham, Israeli-Lev, and Livney (2014) found that β-Lg-
naringenin complexes exhibited no significant effect on the binding stoichiometry and 
no impact on the efficacy of crystallisation suppression of naringenin. Therefore, it 
seems that β-Lg and β-Lg nanoparticles exhibited different binding ability with different 
ligands, and this might relate to binding sites, and the way ligands interacted with 
proteins. Also, binding of resveratrol to native β-Lg followed a Stern-Volmer model with 
binding constant 1.67х105, and the binding number is 1.33  but no model was found to 
fit resveratrol-β-Lg nanoparticles. On the other hand, both resveratrol-native β-Lg and 
resveratrol-β-Lg nanocomplexes expressed higher antioxidant activity under 
Pasteurization conditions compared to resveratrol standard.  
Lastly, the stability of β-Lg nanoparticles was examined under different laboratory 
processes and conditions (chapter 4), which might relate to the further study of industry 
applications. Linked with resveratrol study, ethanol was tested as a possible solvent to 
improve resveratrol’s solubility. The addition of ethanol led to larger aggregates and 
reduction of the charge of particles (zeta-potential). Application of high-speed 
centrifugation resulted in the sedimentation of nanoparticles and loss of protein 
concentration in supernatant. Moreover, it was found that there was no difference in 
the particle size of resuspended freeze dried samples and freshly prepared samples.  
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Meanwhile, whey nanoparticles were produced by the same method developed for β-
Lg using sweet whey made from skimmed milk. The size of whey nanoparticles at 0.5% 
w/v protein concentration was similar to that obtained with 0.2% β-Lg (~250nm).  
Overall, in this study, it has been shown that a simple and robust heat-induced 
denaturation method has been developed to produce β-Lg nanoparticles and similar 
nanoparticles can be produced by whey. Nanoparticles were applied to encapsulate 
caffeine and resveratrol to form nanocomplexes with denatured β-Lg. It was highlighted 
that encapsulation of bioactives with β-Lg nanoparticles can result in their controlled 
release and can have a protective effect. These nanoparticles may find an application to 
improve delivery caffeine in the intestinal tract. In the case of resveratrol, potentially β-
Lg can protect it from light and heat degradation, therefore can be used in the 
formulation of resveratrol during thermal processing or storage. To conclude, given the 
growing interest towards health promoting food products, the β-Lg/whey protein 
nanoparticles produced in this study contributed to a possible solution for food 
nanodelivery of nutraceuticals and has contributed with useful knowledge in the 
bioactive compounds protection. It is believed these β-Lg/whey protein nanoparticles 
have the potential for applications in food products with health benefits.  
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5.2. Limitations of the current study and suggestions for further work 
In this work, a robust and reproducible method to produced β-Lg nanoparticles was 
developed, and it was applied to caffeine and resveratrol encapsulation. Indeed, some 
limitations existed in this study, and further research can be carried out. The section 
below mainly discussed the limitations of this work and suggestions for future work.  
The size of β-Lg nanoparticle was 200nm-300nm, which was larger than nanoparticles 
produced by desolvation method (around 100nm) (Gulseren et al., 2012; S. Ko & S. 
Gunasekaran, 2006). In the beginning, the target was around or below 100nm to meet 
the strict definition of nano size (0-100nm). However, nanoparticles produced at pH 6.3 
or above showed low reproducibility, even though the size was smaller and within the 
nano range. Sometimes, a bimodal distribution was obtained with high PDI (>0.3) (Figure 
5.1) and sometimes no nanoparticles above 10nm were obtained. It might indicate that 
the intermolecular interactions among β-Lg molecules were not sufficient to form 
100nm nanoparticles. Some approaches were applied, for example, adding different ions 
to change the ionic strength and change the net charge of protein to promote 
interactions or cross-linking between ions and protein molecules. Some divalent ions 
(Calcium and magnesium) induced aggregation via electrostatic interactions, 
ion/hydrophobic interactions and cross linking with negatively charged carboxylic groups 
of neighbouring protein molecules. Giroux et al. (2010) produced  100-200nm whey 
protein nanoparticles by adding 2.5mM Calcium using pH-cycling treatment method, 
and Phan-Xuan et al. (2014) achieved 100nm-400nm denser microgels in the presence 
of Ca2+ at neutral pH. However, it is also noted that adding ions may influence the binding 
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properties of the protein and this is ill-defined. Therefore it is interesting to carry out 
investigation the influence of ions in nanoparticles formation, size and binding 
properties.  
 
Figure 5.1: An example of the multi-size distribution of 0.2%w/v β-Lg solution at pH 7.5 
for 75°C for 45mins. 
On the other hand, the nanoparticles produced in the present study were mainly 
stabilised by hydrogen bonding and hydrophobic interactions, not by the disulphide 
bonds. This is mainly due to the acidic conditions and the low protein concentration used 
in the method developed here. Therefore, it might be the reason why rapid particle 
degradation and high burst effect of caffeine release in simulated gastric fluid was found. 
Meanwhile, even though the maximum encapsulation efficiency (13.54%) was relatively 
low, a sensory experiment could be conducted to examine the masking of bitterness by 
encapsulation of caffeine. The caffeine has a detection threshold at 1.2Mm, and there 
was a specific concentration (6 mM), where bitter taste can be perceived and could be 
differentiated (Keast & Roper, 2007). Based on this concentration, the masking function 
of encapsulation could be investigated; it is worth noting that the ethical assessment 
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would need to be conducted carefully as the overdosage of caffeine could lead to 
poisoning.   
In the resveratrol encapsulation study, the resveratrol could not be quantified by high-
performance liquid chromatography due to the filtration limitation. Thus, the separation 
of free resveratrol and bound resveratrol could not be achieved, and the encapsulation 
efficiency could not be determined. In fact, there was a proposal to carry out 
encapsulation by dissolving resveratrol in ethanol since resveratrol could be filtered in 
ethanol. However, there was a concern that adding ethanol would lead to solubilisation 
of resveratrol in ethanol predominantly, which would hinder its encapsulation or 
complexation with β-Lg. Moreover, free resveratrol in 28% v/v ethanol/water solution 
had low permeability through ultrafiltration membrane (50KDa MWCO, Vivaspin® 20, 
Sartorius Stedim Biotech, Germany). Another idea was after dissolving resveratrol in 
ethanol and making nanoparticles, an evaporation step was applied to eliminate ethanol. 
However, even heating at 75°C for two hours, only limited ethanol was evaporated. 
Pujara et al. (2017) proposed that using reduced pressure in a rotary evaporator could 
eliminate ethanol. Nevertheless, β-Lg nanoparticles proved to have a protective function 
on the antioxidant activity of resveratrol under pasteurisation, and it might be helpful in 
improving the bioavailability of resveratrol. On the other hand, Circular dichroism 
spectra can be investigated to characterise the secondary structure of proteins due to 
the peptide bond absorption.  
Lastly, whey protein nanoparticles were produced by our method and even a smaller 
particles size than β-Lg nanoparticles at the same protein concentration achieved. 
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Further characterization needs to be conducted to explore the predominant interaction 
to form the nanoparticles. Also, the yield of whey protein nanoparticle (72%-85%, 
depending on protein concentration) was relatively low compared with pure β-Lg 
nanoparticles (over 90%). An ultrafiltration step was suggested to be applied to eliminate 
the larger proteins from the whey and proteins which did not form the nanoparticles. 
Some encapsulation experiments like caffeine and resveratrol could be carried out with 
whey protein nanoparticles to make a comparison between β-Lg/whey protein 
nanoparticles. 
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